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Trichodysplasia spinulosa-associated polyomavirus small T antigen activates MAPK pathway
JH Wu,1 H Nguyen,2 R Simonette,1 PL Rady1 and SK Tyring1 1 Department of Dermatology, 
University of Texas Health Science Center, Houston, TX and 2 Baylor College of Medicine, 
Houston, TX
Trichodysplasia Spinulosa (TS) is a disfiguring skin condition characterized by abnormal maturation 
of hair follicles, dysplasia of inner root sheath cells, keratin spine formation on the central face, and 
alopecia. TS occurs exclusively in immunocompromised patients and results from infection with 
Trichodysplasia Spinulosa-Associated Polyomavirus (TSPyV). Although the association between 
TSPyV and TS has been recognized, the mechanism by which TSPyV mediates the pathogenesis 
of TS is poorly understood. Similar to other polyomaviruses, the TSPyV genome encodes the small 
T (sT) antigen. While several polyomavirus sT antigens bind and inhibit protein phosphatases, the 
specific function of protein phosphatase 2A (PP2A) in small T antigen pathogenesis remains to be 
further defined. Moreover, it remains unknown whether and which phosphatase might be implicated 
in TSPyV sT antigen actions. The purpose of the current study is to understand the proliferative 
role of TSPyV sT antigen by investigating its binding capacity to protein phosphatase 2A (PP2A) 
and to determine its effect on the activation of MAPK and AKT, two characteristic PP2A targets 
that influence cell proliferation. We performed co-immunoprecipitation and His-tag pull-down 
assays to evaluate the interaction between TSPyV sT antigen and PP2A. Under both assay systems, 
we observed that TSPyV sT antigen physically associated with PP2A. We subsequently examined 
the phosphorylation of MEK-1/2, ERK-1/2, and AKT in cultured cells overexpressing TSPyV sT 
antigen. Our data showed that overexpression of TSPyV sT antigen enhanced the phosphorylation 
of MEK-1/2 and ERK-1/2, but not AKT. These findings provide novel evidence for a distinct role of 
PP2A in mediating the actions of TSPyV small T antigen. Our results demonstrate that TSPyV sT 
antigen, by binding and inhibiting PP2A, can activate the MAPK pathway and thus contribute to 
the proliferative nature of TS.    
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Recognition of melanoma by an innate immune receptor Dectin-1 orchestrates innate immune 
cells for anti-tumor responses
H Ikushima Institute of Industrial Science, Max Planck-The University of Tokyo Center for 
Integrative Inflammology, The University of Tokyo, Tokyo, Japan
The eradication of cancer cells requires communication between cells which constitute the complex 
immune system. Natural killer (NK) cells are essential tumor-killing effector cells of the innate arm 
of the immune system; however, little is known about whether or how other innate immune cells 
recognize tumor cells to assist NK cells. In addition, although signal-transducing pattern recognition 
receptors are known to play important roles in innate immune responses against invading patho-
gens through recognition of pathogen-associated molecular patterns (PAMPs), it is still enigmatic 
whether and how these receptors contribute to anti-tumor immune responses. In this study, we show 
that the innate immune pattern recognition receptor Dectin-1 expressed on dendritic cells (DCs) 
and macrophages is critical to NK cell-mediated killing activity against melanoma. We also show 
that tumor cell-triggered Dectin-1 signaling in DCs and macrophages is instigated by the receptor 
recognition of N-glycan structures on tumor cells, which we term tumor-associated molecular 
patterns (TAMPs). The TAMP-Dectin-1 signaling causes activation of the Interferon Regulatory 
Factor 5 (IRF5) transcription factor and subsequent induction of genes required for the full-blown 
killing activity of NK cells. The importance of these events is underscored by the observation of 
massive melanoma metastasis in mice genetically deficient in either Dectin-1 or IRF5. Thus, these 
results reveal a hitherto unrecognized facet of pattern recognition receptors in the orchestration of 
anti-tumor innate immune responses; recognition of TAMPs. This study is the first to demonstrate 
that an innate immune pattern recognition receptor potentiates anti-tumor immune responses, 
offering new insight into anti-tumor activity of the innate immune system with implications for 
anti-tumor immunotherapy.    
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Use of a translational human ex-vivo skin model to predict clinical effective dose of a topical 
drug candidate
J Neil,1 J Brusq,2 CE Peredo,1 SH Smith,1 B Millerman,1 L Santos,1 M Bedard,1 F Viviani2 and 
J Cote-Sierra1 1 Center for Skin Biology, Stiefel, a GSK Co, Research Triangle Park, NC and 2 
GlaxoSmithKline, Les Ulis, France
We postulated that topical target engagement could be demonstrated in human skin prior to clinical 
POC trials. Indeed, a therapeutic compound formulated for topical delivery can be shown to affect 
specific disease-relevant biomarkers using a novel ex-vivo human skin culture system. The custom 
design of Franz Cells allows topical delivery of drug compounds through the skin barrier to be 
interrogated with repeated applications of drug to imitate clinical trial applications. Treatment using 
Franz cells ensured localized, contained, and reproducible application. Systemic application, in the 
basolateral compartment, of a Th17 “polarization” cocktail was studied in the presence of a potent 
and selective control antagonist applied apically. Polarization of skin resident T cells into Th17 cells 
and compound efficacy was monitored by qPCR, and the integrity of the skin barrier was assessed by 
TEWL. The dose range finding implications allow for better prediction of efficacious concentrations 
prior to first time in humans. This experimental design is the first to reliably limit the exposure of 
the compound to the surface of human skin to detect dermal and epidermal target engagement. 
This unique design enabled us to perform multiple applications of the compound to assess PK/
PD relationships in a human tissue maintained in an air-liquid interface mimicking physiological 
conditions. Thus, we can not only analyze disease-state biomarker regulation, but also compare 
different concentrations and formulations proposed as candidates for human testing. This approach 
employs a novel chamber system designed specifically for culture of human skin, more directly 
testing compound interactions without the need for animal subjects. This methodology provides a 
platform to interrogate novel topical therapeutics we are advancing for the treatment of skin disease.   
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GSK compound A Inhibits keratinocyte and T lymphocyte proliferation and cytokine produc-
tion by blocking cell cycle progression at the G1-S transition phase
T Bui,1 C Coquery,1 D Rickard,2 J Moore,2 SH Smith1 and J Cote-Sierra1 1 Center for Skin 
Biology, Stiefel, a GSK Company, Research Triangle Park, NC and 2 PTS, Glaxo Smith Kline, 
Research Triangle Park, NC
In psoriasis, an excessive accumulation of cells including keratinocytes and lymphocytes are 
observed in disease pathology. Dysregulated keratinocytes proliferate rapidly and epidermal dif-
ferentiation is altered resulting in raised, psoriasiform skin placques. In addition, accumulation of 
inflammatory T cells secreting IL-17a(Th17) in perivascular clusters of the dermis and epidermis 
have been implicated in contributing to disease pathology. Phenotypic screening showed that 
compound A inhibited IL-17 cytokine production by T cells as well as keratinocyte proliferation. 
Therefore, we sought to determine if a) the biological effect of Compound A is due to a direct effect 
on cytokine production or to an effect on the proliferation of inflammatory Th17 cells and b) whether 
the inhibition of keratinocyte proliferation is mediated by alterations in the cell cycle. Compound A 
treatment during Th17 polarization of CD4 T cells inhibited cell division in a concentration depen-
dent manner. As a result of this block, Th17 differentiation was inhibited resulting in a reduction 
of IL-17a+ cells. Cell cycle studies showed that Compound A treatment of keratinocytes altered 
the frequency of cells within the G1, S, G2/M cell cycle phases. Chemically induced cell synchro-
nization experiments in keratinocytes further implicate a cell cycle block at the G1/S transition. 
We propose that prolonged inhibition of the cell cycle by compound A preceded and ultimately 
resulted in the induction of apoptosis. Overall, compound A mediates inhibition of proliferation 
and cytokine production in two major cell types of the skin, keratinocytes and T cells, implicated 
in chronic inflammation in psoriasis.    
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AN2728, a new boron-based topical anti-inflammatory agent, inhibits phosphodiesterase 
4 (PDE4)
Y Freund, C Dong, C Virtucio-Frates, F Rock, Y Mak, Y Zhou, L Zane and K Jarnagin Anacor 
Pharmaceuticals, Inc., Palo Alto, CA, Palo Alto, CA
These studies were conducted to further characterize the mechanism of action of AN2728, a novel 
boron-based topical anti-inflammatory agent being investigated in phase 3 clinical trials for treat-
ment of mild-to-moderate atopic dermatitis. The mechanism of action of AN2728 was characterized 
via enzyme kinetic assays, PDE4 subtype inhibition studies, protein crystallography, and an analysis 
of cytokine inhibition in peripheral blood mononuclear cells. To investigate reactivity against other 
targets, AN2728 was tested against 50 receptors and ligand-gated ion channels for inhibition at 10 
μM. AN2728 competes with cAMP to inhibit the PDE4B1-catalytic domain with a Ki of 173±26 nM; 
thus AN2728 interacts at the enzyme-active site. The X-ray structure of PDE4B-catalytic domain 
with AN2728, and its structural relative, AN2898, reveals that the boron atom interacts with the 
bimetal center and occupies a position in the catalytic site similar to that of the cAMP phosphate. 
AN2728 has good affinity across the PDE4 gene products A-D. Its selective affinity for PDE4 is 
4- to 10-fold greater than its affinity for PDE1, 2, 3A, 6, or 7B. It is inactive on PDE3B, 5, 7A1, and 
8-11. The activity of AN2728 results in an increase in intracellular cAMP and activation of PKA, 
followed by phosphorylation and negative regulation of transcription factors of various cytokines. 
In the analysis of AN2728 binding to 50 receptors and ligand-gated ion channels, inhibition was 
less than 25% for all of the receptors tested; thus, AN2728 is specific for PDE4. AN2728 exerts its 
anti-inflammatory effect by inhibition of PDE4, one of 11 subtypes of the enzymes that catalyze the 
breakdown of cyclic nucleotides to their inactive monophosphates (in the case of PDE4, cAMP to 
AMP). Through inhibition of cAMP-dependent PDE4 activity, AN2728 inhibits the production of 
specific cytokines with a pattern that is notably similar to that of other established PDE4 inhibitors 
and distinctly different from those of a glucocorticoid and a calcineurin inhibitor.    
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Dysbiotic microbiota drives atopic inflammation in Adam17fl/flSox9-Cre mice
T Kobayashi1, 2, M Glatz,2 K Horiuchi,3 T Doebel,2 D Kaplan,4 HH Kong,2 M Amagai1 and 
K Nagao1, 2 1 Dermatology, Keio University School of Medicine, Tokyo, Japan, 2 Dermatology 
Branch, NCI, NIH, Bethesda, MD, 3 Orthopedic Surgery, Keio University School of Medicine, 
Tokyo, Japan and 4 Dermatology, Center for Immunology, University of Minnesota, 
Minneapolis, MN
Staphylococcus aureus universally colonizes skin of patients with atopic dermatitis (AD), while Cory-
nebacterium species can also be detected in genetic diseases that manifest eczematous dermatitis. 
The causal relationship between dysbiosis and AD has yet to be determined. Recently, ADAM17-de-
ficiency was identified as a new genetic disease that manifests eczematous dermatitis. Here we 
show in Sox9-Cre; Adam17fl/fl (Adam17ΔSox9) mice, that the atopic phenotype they exhibited, dry, 
eczematous and pruritic skin, high serum IgE and CCL17 and a mixture of enhanced T cell responses, 
critically depended on dysbiotic microbiota. Longitudinal microbiome analysis revealed sequential 
changes in skin bacterial communities. While microbiota in WT and Adam17ΔSox9 mice were diverse 
and indistinguishable at week 2 after birth, Corynebacterium mastitidis emerged in Adam17ΔSox9 mice 
at week 4, followed by S. aureus from week 6. C. mastitidis was abruptly replaced by C. bovis at 
week 8. Antibiotic treatments reversed dysbiosis and protected mice from developing eczematous 
inflammation. On the contrary, withdrawal of antibiotics resulted in rapid emergence of dysbiosis 
and eczematous inflammation. Inoculation of S. aureus onto antibiotic-pre-treated Adam17ΔSox9 
mice markedly enhanced eczematous dermatitis whereas C. bovis inoculation induced prominent 
Th2 responses, formally demonstrating that specific components of the skin microflora can mod-
ulate eczematous inflammation. Impairment of EGFR signaling, a major downstream pathway of 
Adam17, was sufficient to initiate dysbiosis. Taken together, this study reveals crucial contributions 
of commensal bacteria during eczematous inflammation in mice and provides impetus for exploring 
novel therapies that target the microbiota-host immunity axis in AD.    
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IL-1β-independent neutrophil recruitment induces long-term protection against a Staphylo-
coccus aureus skin reinfection
C Page, D Lee, Y Wang, J Shahbazian, A Ashbaugh and LS Miller Dermatology, Johns 
Hopkins University, Baltimore, MD
S. aureus skin reinfections in patients are common, especially those caused by community-acquired 
methicillin-resistant S. aureus (CAMRSA). We previously reported that IL-1β induced neutrophil 
(PMN) recruitment and bacterial clearance during a primary S. aureus skin infection in mice. How-
ever, the immune responses that promote protection against S. aureus skin reinfections are not clear. 
We developed a CA-MRSA (USA300 LAC::lux; 3x107 CFU, intradermally) skin reinfection model 
in mice involving a primary infection (1°) in the lower back (which cleared by 14 days) followed 
by a secondary infection (2°) in the upper back on day 28. Wt mice developed little protection as 
2° wt mice had smaller lesions than 1° wt but the bacterial burden was identical. In contrast, 2° 
IL1β-/- mice were rescued from the larger lesions and higher bacterial burden in 1° IL-1β-/- mice. 
This protection was long-lasting as it was still present if we waited 8 weeks between 1° and 2° 
infections. By histology on day 1, the impaired PMN abscess formation in 1° IL1β-/- mice was 
restored in 2° IL-1β-/- mice to levels seen in wt mice. In the blood at 6 hours, the PMN trafficking 
defect in 1° IL-1β-/- mice (indicated by higher numbers of CD11b+/Ly6G+ PMNs) was also rescued 
in 2° IL-1β-/- mice, which had lower numbers of PMNs, similar to wt mice. In the skin at 6 hours, a 
23-plex protein array for inflammatory cytokines/chemokines revealed a marked defect in IL-6 levels 
in 1° IL-1β-/- mice, which was restored in 2° IL-1β-/- mice to levels seen in wt mice, suggesting a 
role for IL-6 in the immune protection. Taken together, in the absence of IL-1β, an alternative and 
potentially novel mechanism for PMN recruitment developed that mediated long-term protection 
against a CA-MRSA skin reinfection.    
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Role of filaggrin-deficiency, skin injury and Staphylococcus aureus in atopic dermatitis-like 
skin inflammation in mice
N Archer,1 Y Wang,1 R Ortines,1 A Ashbaugh,1 C Page,1 M Oyoshi,2 R Geha2 and LS Miller1 
1 Dermatology, Johns Hopkins University, Baltimore, MD and 2 Pediatrics, Boston’s Children 
Hospital, Boston, MA
Atopic dermatitis (AD) is associated with filaggrin loss-of-function mutations, which contribute to 
the skin barrier defect in this disease. In addition, Staphylococcus aureus colonizes and exacerbates 
AD, however, it is unclear whether S. aureus contributes to the pathogenesis of AD in the context of 
filaggrin mutations. To model AD-like skin inflammation, we performed scalpel cuts on the backs 
of filaggrin-deficient (ft/ft) and wt (Balb/c) mice (which are Th2 biased) to mimic skin injury from 
scratching in AD patients. Three weeks following skin injury, ft/ft mice but not wt mice developed 
AD-like skin inflammation at the site of injury (clinically: erythema, scale; histologically: acanthosis 
and dermal inflammation with influx of eosinophils, neutrophils and mast cells). Of note, histologic 
analysis of lesional and non-lesional skin revealed constitutive IL1β expression in the epidermis of 
ft/ft but not wt mice, suggesting a potential role for IL-1β in mediating AD-like skin inflammation. To 
determine the role of S. aureus in contributing to the AD-like skin inflammation, S. aureus (SF8300, 
3x106 CFU) was inoculated onto the injured skin. Interestingly, the combination of skin injury and S. 
aureus resulted in AD-like inflammation in wt mice but did not alter the AD-like skin inflammation 
induced by skin injury alone in ft/ft mice. Taken together, skin injury alone was sufficient to induce 
AD-like inflammation in the setting of filaggrin deficiency whereas the combination skin injury and 
S. aureus inoculation resulted in the development of AD-like inflammation in wt mice. These results 
suggest that skin injury may be a more important determinant than S. aureus colonization for the 
development of AD in patients with filaggrin mutations.    
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Integration of IL17 and TNF responses in human keratinocytes
S Ramaswami,1 ME Anderson1 and MS Hayden1, 2 1 Dermatology, Columbia University 
Medical Center, New York, NY and 2 Microbiology & Immunology, Columbia University 
Medical Center, New York, NY
Psoriasis is a chronic inflammatory disorder characterized by hyperproliferation of keratinocytes and 
consequent development of red scaly skin plaques. The pro-inflammatory cytokines IL17 and TNF 
are strongly implicated in psoriasis, most directly by the clinical efficacy of anti-TNF and anti-IL17 
biologics. TNF and IL17 are proposed to act synergistically to induce a gene expression profile in 
keratinocytes that shares significant overlap with the transcriptome of psoriatic lesions. However, 
there are several potential points of cross-talk between TNF and IL17 signaling pathways and the 
mechanism of TNF and IL17 synergy remains unclear. Here, we demonstrate directionality within 
this synergy, wherein IL17 augments TNF-induced gene expression in human keratinocytes. The 
effects of TNF are shaped by the chronicity of stimulation: the duration of keratinocyte exposure to 
TNF can drastically alter the magnitude and kinetics of pro-inflammatory gene expression. Conse-
quently, a single brief exposure to TNF results in a short-lived transcriptional response in cultured 
keratinocytes. Simultaneous exposure to IL17 drastically alters the response of keratinocytes to TNF 
stimulation. As a result, production of pro-inflammatory factors by keratinocytes exposed to brief 
pulses of TNF in the presence of IL17 mimic the response to sustained, high-level TNF stimulation. 
This enhanced response is independent of IL-17 effects on NF-kB activation. Instead, we find that the 
IL17 increases stability of several TNF-induced transcripts that are known to be upregulated in pso-
riasis. These findings provide a basis for understanding why TNF and IL17 are necessary but not suf-
ficient for psoriasis pathogenesis and highlight the potential of developing anti-psoriatics that spare 
normal, protective, biological functions of cytokine by targeting mechanisms of cytokine synergy   
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Expression of toll like receptors 3, 7, 8, and 9 in peripheral blood mononuclear cells from 
patients with psoriasis 
H Kim, S Kim, J Je, D Kim, D Shin and M Lee Department of Dermatology, Yonsei University 
College of Medicine, Seoul, Korea (the Republic of)
This study was to evaluate gene expression level of intracellular TLR in peripheral blood mono-
nuclear cells (PBMC) from psoriatic patients. Changes in TLR3, TLR7, TLR8 and TLR9 expression 
were evaluated using quantitative real-time reverse transcription polymerase chain reaction and 
flow cytometry in PBMC from 22 patients with psoriasis and 5 healthy controls, along with changes 
in inflammatory cytokine levels. The gene expression of all TLRs evaluated were significantly aug-
mented in psoriatic patients compared with controls, and patients with more recent aggravation 
showed more up-regulation of TLR. Cytokine levels, including TNF-α, IFN-γ, IL-10, IL-12, IL-17A, 
IL-22 and IL-23, were significantly increased compared with healthy controls, while increased IL-6, 
IL-8, and IL-21 level was not statistically significant. Increased expression of intracellular TLRs, 
TLR3, TLR7, TLR8 and TLR9 on PBMC in psoriatic patients and clinical correlations together with 
inflammatory cytokine profiles suggest that the innate immune response involving TLRs could play 
a role in the pathomechanism of psoriasis.    
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Bacteria in the human skin microbiome mediate glycerol fermentation against Malassezia 
furfur
M Kao,1 Y Lee,1 Y Wang,2 RL Gallo2 and C Huang1, 2 1 Taiwan National Central University, 
Taoyuan, Taiwan and 2 University of California, San Diego, CA
Malassezia furfur (M. furfur), a fungus in the human skin microbiome, is found growing on the skin 
of most adults. By fingerprint analysis, we have identified two skin bacteria that can fermentatively 
metabolize glycerol and create inhibition zones against M. fufur. Co-culture of skin bacteria with 
M. furfur in the presence of glycerol in vitro hinders the growth of M. furfur. By nuclear magnetic 
resonance (NMR) analysis, we found that acetic and butyric acids are two major short-chain fatty 
acids (SCFAs) in the fermentation media of skin bacteria. Butyric acid, but not acetic acid, increases 
the acetylation levels of Histone 3 at Lysine 9 (AcH3K9) in primary human keratinocytes. Treat-
ment of human keratinocytes with butyric acid markedly reduces the level of interleukin (IL)-1β. 
Results from the minimal bactericidal concentration (MBC) assays demonstrate that both acetic 
and butyric acid display excellent anti-fungal activities against M. fufur. By performing the 16S 
rRNA and 28S rDNA sequencing, we have identified four bacteria and five fungi including M. 
furfur coexisting in human dandruff. Incubation of butyric or acetic acid with dandruff significantly 
decreases the growth of fungi in dandruff. Our study emphasizes the probiotic activity of bacteria 
in the human skin microbiome against M. fufur, which has been linked to several skin diseases, 
including seborrheic dermatitis, folliculitis, confluent and reticulated papillomatosis, and pityriasis 
versicolor. SCFAs and their analogs as novel anti-fungal agents with high potential for treatment of 
M. fufur-associated skin disorders.    
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Unprocessed IL-36α regulates psoriasis-like skin inflammation in co-operation with IL-1α
H Fu, KA Milora, O Dubaz and L Jensen Temple University School of Medicine, Philadelphia, 
PA
Psoriasis has been linked to overzealous IL-1 and IL-36 signaling; however, whether these cyto-
kines have redundant, interrelated or independent functions have not been examined. It is also 
unknown if the IL-36 cytokines undergo processing in vivo. Using the imiquimod-induced skin 
inflammation model, we previously showed that IL-1α, via the receptor IL-1R1, plays an important 
role in initiating psoriasiform disease. Here, we examined IL-36 protein expression, functional 
involvement and interaction with IL-1α/IL-1R1 signaling. Normal skin did not express detectable 
levels of IL-36α, IL-36β, or IL-36γ. Following imiquimod treatment all 3 cytokine mRNAs were 
up-regulated; however, only IL-36α secretion could be detected in explant skin cultures. Signifi-
cantly less (25%, p<0.01) was released from IL-1R1 deficient skin. Surprisingly, the released IL-36α 
migrated in SDS-PAGE similar to a full-length recombinant form suggesting that IL-36α does not 
undergo proteolytical processing. Using knockout (KO) mice for each individual IL-36 cytokine, we 
found that IL-36α, but not IL-36β and IL-36γ, significantly contributed to pathology. Specifically, 
we observed thicker epidermis (approximately 2-fold, p<0.01) and increased dermal edema (1.5 
fold, p<0.05) and inflammation in wild type compared to IL-36α KO mice. Neutrophil recruitment 
to the epidermis was impaired in the IL-36α KO mice, but could be rescued with application of 
the chemokine CXCL1. IL-36α also regulated IL-1α expression through a feedback mechanism. To 
examine interactions between IL-1 and IL-36α signaling, we generated IL-1R1/IL-36α double KO 
mice. After imiquimod challenge epidermal and dermal thickness was significantly greater (p<0.05) 
in single than double KO mice. This demonstrates that IL-1α and IL-36α augment the psoriasis 
promoting activity of the other cytokine. In summary, we conclude that IL-1α and IL-36α form a 
self-amplifying inflammatory loop that in patients with insufficient counter regulatory mechanisms 
may become hyper-engaged and/or chronic.    
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Topical application of acidic formulation alleviates psoriatic symptoms in imiquimod-induced 
psoriasis model
S Kim, S Kim, S Lee and S Jeong NeoPharm Co., Ltd, Daejeon, Korea (the Republic of)
Acid mantle in the stratum corneum maintains the skin surface pH within its normal acidic range. 
Impairment of acid mantle and increased pH triggers and/or exacerbates the inflammatory responses 
in skin, which, at least in part, results from the increased protease activity and activation of pro-
tease-activated receptor (PAR)-2. Previously, we reported that topical application of PAR-2 antag-
onist alleviated the inflammatory symptoms in flaky tail mouse model and oxazolone-induced 
AD model. Interestingly, topical PAR-2 antagonist also alleviated the psoriasis-like symptoms in 
imiquimod-induced psoriasis animal model. To further investigate the roles of skin pH in psoria-
sis, in this study, we tried to evaluate the effects of topical acidic formulation on psoriasis, using 
imiquimod-induced animal models. 5% imiquimod cream was topically applied in the back and 
ear of female hairless mouse and acidic formulation (pH 3.5) was topically applied on the same 
sites for 7 days. Skin thickness, erythema and trans-epidermal water loss (TEWL) as a representation 
of epidermal permeability barrier function, were measured during the application period. After the 
application, skin biopsy was taken for further histological assessments. As a result, prevention of 
skin thickening and barrier function disruption were observed in acidic formulation applied site.. 
Immunohistochemical observation confirmed the decreased expression of inflammatory cytokine 
(IL-8, IL-17, and IL-23) in acidic formulation applied site, compared with the vehicle treated site. 
These results suggest that maintaining skin surface pH within its normal range is important for many 
inflammatory skin diseases, including psoriasis.    
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Brimonidine tartrate inhibits norepinephrine plus adenosine-5’-triphosphate-induced inter-
leukin 6 and interleukin 8 production by human dermal microvascular endothelial cells
C Guo, LL Stohl and RD Granstein Weill Cornell Medical College, New York, NY
Brimonidine tartrate gel is used clinically to treat facial erythema in rosacea. It is a selective α2-ad-
renergic receptor agonist that induces vasoconstriction, resulting in redness reduction. We have now 
examined whether brimonidine may also exert anti-inflammatory effects by suppressing chemokine 
production by microvascular endothelial cells. Cells of a human dermal microvascular endothelial 
cell line (HMEC-1) were plated into 1 mL of depleted medium (2% FBS) at 2 x 105 cells/well in 
12-well plates. After overnight incubation, the medium was replaced and 10 μL of varying concen-
trations of brimonidine tartrate was added. One hour later, 10 μL of 10-6 M norepinephrine (NE) and 
10 μL of 50 μM adenosine-5’-triphosphate (ATP) were also added into each well. All conditions were 
set-up in triplicate. Supernatants were collected 24 hours later and assayed for cytokine/chemokine 
production. We have previously shown that NE and ATP together are capable of strongly stimulating 
interleukin 6 (IL-6) release by HMEC-1. Stimulated IL-6 production was significantly decreased 
when the cells were pretreated with brimonidine. NE plus ATP also induced interleukin 8 (CXCL8) 
production and brimonidine also significantly inhibited production of this chemokine. Similar 
preliminary experiments utilizing primary neonatal human dermal microvascular endothelial cells 
demonstrated that brimonidine also significantly inhibited NE plus ATP-induced IL-6 and CXCL8 
production by those cells. Thus, beneficial effects of brimonidine treatment for rosacea may result, 
in part, from inhibition of cytokine/chemokine production and consequent decreased inflammation.   
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Quantitative correlation of pruritus with functional connectivity MRI in the brain of mice 
with psoriasiform dermatitis
X Liu, Y Imai and S Hwang Dermatology, Medical College of WI, Milwaukee, WI
Functional connectivity MRI (fcMRI), a specific form of MRI imaging, quantitatively assesses connec-
tivity between brain regions that share functional properties. Scratching as a response to pruritus has 
been known to impact quality of life for many psoriasis patients and has also been noted in several 
studies of psoriasiform dermatitis (PD) in mice. FcMRI has already provided unique insights into 
changes in the brain in patients with conditions such as depression and chronic pain, symptoms 
that have been reported by psoriasis patients with pruritus. We quantitatively measured scratching 
behavior in mice in response to pruritus and to correlate the results with fcMRI findings. We treated 
skin daily with the toll-like receptor agonist, imiquimod-(IMQ), to induce PD. A potent glucocorti-
coid, clobetasol (Clo) was applied to suppress PD. Age-matched C57BL/6 mice were divided into 
4 groups: vehicle treated (VT) 4 day, IMQ 1 day, IMQ 4 day, IMQ 4 day+Clo 2day. Under sedative 
anesthesia, all mice underwent 9.4 T fcMRI scans with MRI parameters set at TR= 1s, TE= 18ms, 
NR= 600, and FOV= 2.0x2.0cm2. Brain insula regions, due to their suggested role in stress, were 
chosen as seed regions for fcMRI analysis. Within 20 min of video observation, mice in the IMQ 1 
day and 4 day treatment groups spent ~20-fold more time scratching their skin compared to mice 
in the VT group ( P<0.01). Two daily clobetasol treatments significantly decreased the scratching 
time compared to results in the IMQ 4 day group (1 to 6 fold, P<0.05). The relative insular fc in the 
primary somatosensory cortex (S1) was highly correlated with scratching time (R2=0.98, P=0.008), 
suggesting that fcMRI change can be an objective and sensitive marker to assess pruritus that 
accompanies psoriasis in many patients. Our data suggest that fcMRI methodology may potentially 
be used to screen for agents that reduce pruritus in conditions such as psoriasis.    
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The antimicrobial peptide human beta-defensin 3 induces regulatory T cell
T Schwarz, A Bruhs and A Schwarz Department of Dermatology, University Kiel, Kiel, 
Germany
Antimicrobial peptides (AMPs) are responsible for antibacterial defense and released by a variety of 
cells including keratinocytes. AMPs exert additional activities beyond their antimicrobial capacities, 
e.g. influencing the adaptive immune system by modulating antigen presenting cells. We observed 
that the UV-inducible murine AMP beta-defensin 14 (mBD14) induces regulatory T cells (Treg). 
To clarify whether this applies also for the human system, we studied whether human beta-defen-
sin 3 (hBD3), the human orthologue of mBD14, exerts similar features. Human peripheral blood 
mononuclear cells were separated into CD4+CD25+ (Treg) and CD4+CD25- T cells by magnetobead 
separation. The non-regulatory CD4+CD25- fraction was incubated with hBD3. FACS analysis 
revealed significant upregulation of the Treg characteristic molecules Foxp3, neuropilin, CTLA-4 
and GARP. To address the functional relevance, CD4+CD25− T cells were treated with hBD3 for 48 
hours and cocultured with CD4+CD25− responder T cells in the presence of anti-CD2-, anti-CD3- 
and anti-CD28-loaded microbeads. hBD3-treated CD4+CD25- T cells significantly suppressed the 
antibody triggered proliferation of the responder cells, indicating induction of suppressive features 
of T cells upon incubation with hBD3. These data provide evidence that hBD3 similar to its murine 
analogue may change phenotypic and functional properties of non-regulatory T cells towards sup-
pressive Treg. Through this ability, human AMP may protect the host from microbial attacks on the 
one hand, but tame T-cell-driven reactions on the other hand, thereby enabling an antimicrobial 
defense without collateral damage by the adaptive immune system.    
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The antimicrobial peptide cathelicidin LL-37 induces semaphorin 3A production in normal 
human epidermal keratinocytes
Y Umehara,1 Y Kamata,1 M Tominaga,1 F Niyonsaba,2 H Ogawa1, 2 and K Takamori1, 3 1 
Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate 
School of Medicine, Urayasu-shi, Japan, 2 Atopy (Allergy) Research Center, Juntendo 
University School of Medicine, Bunkyo-ku, Japan and 3 Department of Dermatology, 
Juntendo University Urayasu Hospital, Urayasu-shi, Japan
Increased epidermal nerve density is partly responsible for peripheral itch sensitization in dry skin-
based skin diseases such as atopic dermatitis (AD). We previously found a potential contribution 
of semaphorin 3A (Sema3A) to inhibition of epidermal hyperinnervation in AD. Antimicrobial 
peptides, including, members of two major groups, the cathelicidins and human β-defensins (hBDs), 
are among the primary mechanisms involved in the early stages of immune defense to protect 
skin against microbial pathogens. Reduced expression of antimicrobial peptides in lesional skin 
of AD patients was suggested to increase susceptibility to bacterial and viral infections, particu-
larly Staphylococcus aureus. Here, we investigated the effects of antimicrobial peptides, such as 
LL-37 and hBD-1-4, on Sema3A expression in cultured normal human epidermal keratinocytes 
(NHEK). In our quantitative real-time PCR analyses, the expression of Sema3A mRNA in NHEK 
was increased 4.4-fold (P < 0.001) upon stimulation with LL-37, but not all hBDs, compared with 
controls after incubation for 48 hours. We next examined the signaling pathway of LL-37-induced 
Sema3A expression in NHEK pretreated with different inhibitors and receptor antagonists for 1 hour 
before stimulation with LL-37. The results indicated that LL-37-induced Sema3A expression was 
completely inhibited by the G protein α subunit Gi inhibitor pertussis toxin and ERK1/2 signaling 
inhibitor PD98059, but not antagonists of FPRL1 and P2X7R. These results suggest that LL-37 induces 
Sema3A expression in NHEK via certain Gi-coupled receptors and the ERK1/2 signaling pathway.   
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Antimicrobial and anti-inflammatory effects of Helicobacter pylori-derived synthetic antimi-
crobial peptides against Staphylococcus aureus in the skin
PI Song,1 S Ryu,3 H Hahn,3 Y Park3 and CA Armstrong2 1 Dermatology, University of 
Colorado Denver Anschutz Medical Campus, Aurora, CO, 2 Dermatology, Denver Health 
Medical Center, Denver, CO and 3 Biotechnology, Chosun University, Gwangju, Korea (the 
Republic of)
Staphylococcus aureus causes a variety of cutaneous infections. In this study, we examined the 
role of Helicobacter pylori-derived synthetic antimicrobial peptides against methicillin-resistant 
and -sensitive S. aureus. HPA3NT3 and ISFGW are previously reported α- helical anitimicrobial 
peptides with enhanced hydrophobicity and positive charge, which promote potent antibacterial 
effects against gram positive and negative bacteria. The minimal inhibitory concentration (MIC) of 
HPA3NT3 against MRSA was less than 6.3 μM (clindamycin MIC is greater than 25 μM). HPA3NT3 
and ISFGW showed no cytotoxicity in vitro against normal human keratinocytes (HK) even at 
concentrations 5-fold higher than those needed for biologic activity. Treatment with HPA3NT3 
and ISFGW significantly blocked S. aureus-induced toxicity and S. aureus invasion in HK cells. 
HPA3NT3 also decreased the expression of IL-8, TNFα, and the rapid fluctuation of intracellular 
calcium through blocking of activated NF-κB signaling pathways associated with TLR2, which are 
induced by S. aureus infection in HK cells. Moreover, HPA3NT3 and ISFGW reduced MRSA bio-
film formation. These results suggest that HPA3NT3 and ISFGW may represent a new therapeutic 
approach to S. aureus skin infection.    
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Nociceptive sensory fibers drive IL-23 from CD301b+ dermal DC and provide protection 
from cutaneous C. albicans infection
SW Kashem and D Kaplan Dermatology, University of Minnesota, Minneapolis, MN
The skin is a highly immunologically active barrier site that provides protection against invading 
pathogens. It is also a highly innervated sensory interface that can directly sense pathogens via 
nociceptive pathways resulting in pain. Innate resistance to C. albicans in mucosal tissues depends 
on early production of IL-17A by tissue resident cells. In the skin, we found that CD4+ TCRαβ T 
cells and TCRγδ T cells but not innate lymphoid cells rapidly produce IL-17A in response to C. 
albicans infection. Efficient clearance required Vγ4 TCRγδ T cells but not TCRαβ cells. In addition, 
production of IL-17A by TCR γδ T cells as well as their proliferation depended on IL-23 derived 
from CD11c+ DC. Using mice lacking individual skin-resident DC subsets, we found that induction 
of IL-17A from TCRγδ T cells and resistance to C. albicans required IL-23 from CD301b+ dermal 
DC. Moreover, RTX inhibition of nociception, cutaneous denervation, and inhibition of the neu-
ropeptide CGRP resulted in a reduction in the number of IL-17A+ TCR γδ T cells and increased 
susceptibility to C. albicans infection. These data define a model in which nociceptive pathways 
in the skin drive production of IL-23 by CD301b+ dermal DC resulting in IL-17A from TCR γδ T 
cells and resistance to cutaneous candidiasis. The ability of nociceptive fibers to interact with skin 
resident DC and augment local resistance to a pathogen represents a novel pathway that could be 
targeted to augment antimicrobial therapy in the skin.    
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Dermal adipocytes protect against invasive Staphylococcus aureus skin infection
L Zhang,1 CF Guerrero-Juarez,2 T Hata,1 R Ramos,2 M Plikus2 and RL Gallo1 1 Dermatology, 
University of California San Diego, San Diego, CA and 2 Developmental and Cell Biology, 
University of California, Irvine, Irvine, CA
We recently observed that S. aureus skin infection correlated with expansion of the dermal fat layer, 
proliferation of preadipocytes and de novo formation of adipocytes at the infected site. Selectively 
blocking adipogenesis using mice with a mutation in Zfp423, or treating normal mice with PPARγ 
inhibitors, led to increased susceptibility to S. aureus infection. The mechanism by which adipo-
genesis protected against infection was through production of the antimicrobial peptide cathelicidin 
(Camp), as stimulation of adipogenesis in vivo and in vitro induced the production of Camp mRNA 
(>40-fold increase) and subsequent abundant cathelicidin protein secretion from differentiating 
adipocytes. Adipocytes from Camp-/- mice lost the capacity to inhibit bacterial growth and Camp-
/- mice treated with the PPARγ inhibitors did not exacerbate infection. These findings suggested for 
the first time that adipocytes are a major defense system against infection and that cathelicidin is the 
major anti-staphylococcal protein controlled by adipogenesis. To better understand the significance 
of these findings in vivo, we now show through use of beta-gal reporter mice that local infection 
induced transcription of Zfp423 and that adipocytes directly detect and respond to products of S. 
aureus. Furthermore, human subjects with high body mass index (BMI>25) showed elevated circu-
lating cathelicidin LL37. We further show that LL37 can induce a shift in interferon beta production 
from dendritic cells to epithelial cells. Since such actions of LL37 as a proinflammatory mediator 
are important in disorders such as psoriasis, this observation provides new insight into how skin 
inflammation and obesity may contribute to inflammatory co-morbidities.    
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IL-9/IL-9R of epidermal keratinocytes in atopic dermatitis: IL-9 induces IL-8 production 
through STIM1 activation and ERK phosphorylation
C Lee,1 C Hong2, 3, 5 and Y Hsin-Su4, 5 1 Dermatology, Kaohsiung Chang Gung Memorial 
Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2 
Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 3 Dermatology, 
National Yang-Ming University, Taipei, Taiwan, 4 National Environmental Toxicology Center, 
National Health Research Institutes, Zhunan, Taiwan and 5 Graduate Institute of Medicine, 
Kaohsiung Medical University, Kaohsiung, Taiwan
Atopic dermatitis (AD) results from aberrant Th2 polarization and epidermal barrier impairment. 
Initially thought to be a Th2 cytokine, IL-9 induces Th9 cells distinct from Th2. Transgenic expres-
sion of IL-9 in mice results in asthma. In human, IL-9/IL-9R are significantly increased in AD skin 
and blood IL-9 levels are correlated with AD severity. Because keratinocytes are the main cells 
contributing to epidermal barrier, we asked whether IL-9R was expressed in keratinocytes; if so, what 
immuno-regulatory role it may play. We measured the expression of IL-9R in skin from AD patients 
and controls and performed in vitro studies on the IL-9-treated keratinocytes. The result showed that 
IL-9R was indeed expressed in keratinocytes but not in fibroblasts. Its expression in keratinocytes 
was enhanced by IL-4 but not by TGF-beta1. IL-9 induced a moderate production of IL-8 but not 
CXCL16 or CCL22. IL-9 induced ERK phosphorylation both dose- and time-dependently, but not 
mTOR, S6K, p38, or STAT3. Pretreatment with U0126 (ERK inhibitor) but not rapamycin (mTOR 
inhibitor) abrogated the IL-9-mediated IL-8 production. Inhibition of STIM1 abrogated ERK phos-
phorylation and IL-8 production induced by IL-9. This study concludes how IL-9-STIM1-ERK-IL-8 
axis in keratinocyte might play an important role in AD.    
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TLR4 acts as a death receptor for ultraviolet radiation (UVR) in antigen presenting cells
H Zhou, E Harberts, R Fishelevich, S Vogel and A Gaspari University of Maryland Medical 
School, Baltimore, MD
UVR-induced apoptosis in antigen-presenting cells (APC) is dependent on TLR4/MyD88 signaling, 
but the downstream signaling pathways have not been defined. We hypothesize UVR engages a 
distinct death signaling pathway distinct from PAMP-induced TLR signaling. We used endotoxin 
tolerance to impair macrophage TLR4 signaling to its classic ligand, lipopolysaccharide (LPS); 
however, this treatment did not impair UVR-induced apoptosis. IRAK4 is necessary for TLR-and 
MyD88-dependent signaling in response to PAMPs. We utilized APC from IRAK4KDKI (catalytically 
inactive IRAK4) mice to study their survival of APC and measurement of apoptosis (cleaved caspase 
3 ELISA) after UVR, and found IRAK4KDKI and WT APC responses were identical. When TLR agonists 
signal through their specific receptors and recruit MyD88, IRAK4 is activated, causing the degra-
dation of IRAK1. Whereas TLR2 (PAM2CSK) and TLR4 agonists (LPS) caused rapid degradation of 
IRAK1, UVR failed to induce degradation of IRAK1 in APC from WT or MyD88-/- mice. Furthermore, 
APC from IRAK4KDKI mice activated caspase 8, caspase 3, and cleaved PARP after UVR and under-
went extrinsic apoptosis as evidenced by RIP1 cleavage and a lack of up-regulation of RIP3 after 
UVR, identically to WT APC (WB). Using confocal microscopy, we observed migration of FADD 
to the cell membrane of WT APC, but not MyD88-/- APC, after UVR exposure. AU1 epitope-tagged 
human MyD88 was over-expressed in the THP-1 cell line. After UVR exposure, we immunopre-
cipitated the epitope-tagged MyD88, and then WB for FADD or TRADD. FADD, but not TRADD, 
was recruited to MyD88 within 30 minutes of UVR exposure. Our data are supports the idea that 
UVR engages TLR4/MyD88 as a death signaling complex, rather than an inflammatory signaling 
pathway classically triggered by PAMP recognition. Our study provides rationale for the future 
development of topical TLR4 modulating therapies to interfere with this death-signaling pathway 
to maintain immune integrity after UVR.    
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Real-time imaging of Bartonella henselae invading mature human erythrocytes
M Ericson,1 G Viera-Damiani,2 M Neves da Silva,2 K Gupta,3 T Soares,2 M Cintra,5 A de 
Almeida,2 V Pelegati,4 A de Thomaz,4 M Baratti,4 H Carvalho,4 CL Cesar4 and P Velho2 1 
Dermatology, University of Minnesota, Minneapolis, MN, 2 Division of Dermatology and 
Department of Pathology, UNICAMP, Campinas, Brazil, 3 Hematology, Oncology and 
Transplantation, Medicine, University of Minnesota, Minneapolis, MN, 4 National Institute 
of Science and Technology on Photonics Applied to Cell Biology (INFABIC), UNICAMP, 
Campinas, Brazil and 5 Dermatology Division and Department of Pathology, Universidade 
de São Paulo, Sao Paulo, Brazil
Bartonella henselae is a causative agent of anemia, cat scratch disease, bacillary angiomatosis, 
recurrent fever, hepatitis, endocarditis, chronic lymphadenopathy, joint and neurological disorders. 
B. henselae are intra-erythrocytic bacteria. However, the process involved in the homing of bacteria 
to RBC is not known. Therefore, the goal of this study was to visualize the B. henselae invasion 
process into enucleated human red blood cells in real time. We took advantage of the unique fluo-
rescence emission spectral profile of the bacteria. We used a linear unmixing approach to separate 
the fluorescence emission spectra of human erythrocytes from native B. henselae when excited at 
488nm. Human blood samples were inoculated with B. henselae and incubated for 60 hours. 3-D 
live images were captured at select intervals using multi-photon laser scanning microscopy which 
revealed bacteria entering mature, erythrocytes over a 60 hour time period. Real-time, multipho-
ton microscopy enabled us to track B. henselae apparent adhesion to and subsequent invasion of 
mature human erythrocytes. Our results corroborate with the clinical findings of anemia related 
to B.henselae infection. B. henselae should be investigated in cases of anemia of unknown origin.   
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Angiogenic peptide-30 (AG-30) activates primary human keratinocytes to produce cytokines/
chemokines via MrgX receptors
C Kiatsurayanon1, 2, F Niyonsaba,2 H Ushio,2 S Ikeda1, 2, K Okumura2 and H Ogawa2 1 
Dermatology, Juntendo University Graduate School of Medicine, Tokyo, Japan and 2 Atopy 
(Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
Besides their antimicrobial activities, skin-derived host defense peptides (HDPs) such as human 
β-defensins (hBDs) and cathelicidin LL-37 also promote keratinocyte proliferation, migration, pro-
duction of cytokines/chemokines and acceleration of wound healing. AG-30, a novel angiogenic 
HDP which has similar properties to LL-37 and hBDs, activates various functions of fibroblasts and 
endothelial cells, including cytokine/chemokine production and wound healing. The aim of our 
study was to investigate whether AG-30 also participates in the regulation of cutaneous immunity 
by activating primary human keratinocytes (PHKs). We observed that AG-30 increased the pro-
duction of various cytokines/chemokines, including IL-6, IL-8, MIP-3α and RANTES in PHKs in 
a dose- and time-dependent fashion. Since the MAPK pathway occupies a central role in a wide 
range of cellular responses, including cytokine/chemokine secretion, we investigated AG-30 effect 
on MAPK activation and found that this peptide enhanced phosphorylation of p38, JNK and ERK, as 
confirmed by western blotting. In addition, AG-30 enhanced activation of NF-κB. These activations 
were required for the AG-30-mediated regulation of cytokine/chemokine production, as evidenced 
by the inhibitory effects of MAPK and NF-κB specific inhibitors. Because Mas-related G-protein 
coupled receptors X1-4 (MrgX1-4) are utilized by various HDPs including LL-37 and hBDs, we 
speculated that AG-30 may also activate PHKs via MrgX receptors. We found that MrgX1-4 were 
constitutively expressed in PHKs and were also up-regulated upon stimulation with TLR ligands. 
Because MrgX1-4 siRNAs reversed the effects of AG-30-induced cytokine/chemokine production, 
this suggested that AG-30 utilizes MrgX receptors to stimulate PHKs. Taken together, our findings 
imply a novel evidence regarding the contribution of AG-30 to the innate immunity of skin through 
activation of keratinocytes.    
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Identification and modulation of cytokines produced from skin-derived innate lymphoid cells
C Coquery, T Bui, SH Smith and J Cote-Sierra Immunology, Stiefel, a GSK Company, 
Research Triangle Parl, NC
Many inflammatory skin diseases are mediated by a variety of known immune cell types within the 
skin and novel cell types continue to be discovered. The development of therapies targeted directly 
for skin disease requires an in-depth knowledge of not only the populations of cells found within 
the skin, but their relative susceptibility and response to drug engagement. Using a combination 
of digestion techniques, we have developed a novel strategy for isolating distinct cell types from 
human skin in order to (i) interrogate their cytokine profile and (ii) examine the capacity of our 
compounds to modulate cytokine production using Multiplex technology and multi-color flow 
cytometry. Focusing specifically on the innate lymphoid cell (ILC) population, we identified a unique 
cytokine repertoire, under Th17 skewing conditions, that includes classical (IL17A, IL17F, IL22) as 
well non-classical (IL6 and CD40L) cytokines. Expression of these cytokines by healthy skin ILCs 
was similarly recapitulated in blood-derived ILCs from healthy donors under skewing conditions. 
Treating skin-derived ILCs with Compound A led to a marked reduction in IL17 (12%, P<0.01) and 
CD40L (25%, P=0.17); however, the susceptibility of blood-derived ILCs to Compound A was less 
pronounced, with minimal changes in cytokine production observed. Taken together, these data 
have not only identified a new biological function for ILCs that may have implications for disease 
pathology, but has also demonstrated a unique effect of one of our drugs. Importantly, our data has 
highlighted key differences in drug response between circulating and skin-resident immune cells, a 
finding that will require significant consideration for future experimental design and drug validation.   
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Role of galectin-7 in pathogenesis of psoriasis: regulation of skin inflammation and epidermal 
homeostasis through two microRNA pathways
H Chen,1 C Lo,1 M Lu,1 Y Lo1, 2, H Chen1 and F Liu1, 2, 3 1 Institute of Biomedical Sciences, 
Academia Sinica, Taipei, Taiwan, 2 Graduate Institute of Immunology, National Taiwan 
University, Taipei, Taiwan and 3 Department of Dermatology, University of California-Davis, 
Davis, CA
Psoriasis is a chronic inflammatory disease manifested as inflammatory cell infiltrations in the 
skin and keratinocyte hyperproliferation. Galectin-7, a β-galactoside-binding protein expressed by 
keratinocytes, has been previously demonstrated to regulate apoptosis in this cell type. We found 
galectin-7 expression was reduced in lesional skin in psoriatic patients compared to non-lesional 
skin. By studying the effects of galectin-7 knockdown in the immortalized human keratinocyte cell 
line HaCaT, we demonstrated that deficiency of this protein resulted in increased production of IL-6 
and IL-8, and enhanced ERK signaling, when the cells were stimulated with a number of different 
agents, including IL-17. These findings were confirmed in human primary epidermal keratinocytes. 
By genome-wide approaches, we identified two microRNAs that are regulated by galectin-7 (i.e., 
miR-146a and miR-203). We have conducted mechanistic analyses and concluded that galectin-7: 
1) suppresses IL-17-induced production of inflammatory mediators by keratinocytes through the 
miR-146a-MAPK/ERK pathway; and 2) suppresses keratinocyte proliferation through the JNK1-miR-
203-p63 pathway. Finally, galectin-7-deficient mice displayed enhanced ear swelling and inflam-
mation in response to intradermal injection of IL-23 (a mouse model of psoriasiform dermatitis). 
Thus, we have established a novel function of galectin-7 in the pathogenesis of psoriasis mediated 
through two microRNAs and associated pathways.    
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SIG1273: A skin protecting cosmetic functional ingredient with a broad spectrum of anti-aging 
and anti-inflammatory properties
JR Fernandez,1 K Rouzard,1 M Voronkov,1 KL Huber,1 C Webb,1 M Stock,1 JB Stock,2 
JS Gordon1 and E Perez1 1 Sigum Dermalogix, Princeton, NJ and 2 Molecular Biology, 
Princeton University, Princeton, NJ
The skin is the first line of defense against environmental, chemical and physical insults. In mobi-
lizing an acute protective response, several different skin-localized cell types release and respond 
to pro-inflammatory cytokines ensuring skin homeostasis and health. However, chronic exposure 
and activation of this response causes damage that contributes to premature aging. As support for 
the potential of SIG1273 (a small molecule isoprenylcysteine analog) in slowing premature aging, 
it has been previously shown to block 1) UVB and TPA-induced cytokine production in cultured 
keratinocytes, 2) inhibit overproduction of IL-4 and IL-17 in T-cell Receptor (TCR)-activated PBMCs 
and 3) nickel-induction of IL-6 and IL-8 in HDMECs. Here we extend these observations to cultured 
human dermal fibroblasts (HDFs), demonstrating SIG1273’s potential to block skin aging, which we 
validate for the first time with human clinical results. SIG1273 successfully blocks UVA-induced 
IL-6 and MMP-1 production in HDFs. In addition, SIG1273 accelerates fibroblast migration in an 
in vitro wound-healing model. Moreover, SIG1273 displays anti-oxidant properties blocking urban 
dust induced oxidation and cytotoxicity in fibroblasts, which is further supported by free radical 
scavenging capacity that exceeds Vitamin E’s activity. These new in vitro data taken together with 
our previous results highlights SIG1273’s potential in targeting multiple mechanisms of skin aging. 
To investigate whether SIG1273 has anti-aging benefits for human skin, it was tested in an existing 
topical formulation in a double-blind clinical study. Results demonstrate the group topically applying 
SIG1273 had significant improvement in skin fine-line and wrinkles, elasticity and firmness as com-
pared to the non-SIG1273 group. Thus, SIG1273 represents a novel cosmetic functional ingredient 
that provides a broad spectrum of benefits for the skin through its anti-oxidant, anti-inflammatory 
and anti-aging properties.    
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IL-17C, TNFα and IL-36 compensate for loss of IL-6 and identify novel signals facilitating the 
transition between uninvolved and involved psoriasis skin
P Klenotic,1 A Johnston,2 T McCormick1 and NL Ward1 1 Derm, Case Western Reserve 
University, Cleveland, OH and 2 Derm, University of Michigan, Ann Arbor, MI
IL-17C is proinflammatory and highly expressed in lesional psoriasis skin. Mice engineered to 
overexpress IL-17C in KCs (K5-IL-17C) develop a skin disease phenocopying human psoriasis, 
including well-demarcated uninvolved (PN) and involved (PP) skin. PN skin from K5-IL-17C mice 
has increased IL-6 and TNFα protein (~2.5-fold; P<0.05) vs. controls and these increase ~10-fold 
in PP skin (P<0.05) suggesting a role for these molecules in the PN-PP transition. We hypothesize 
that IL-6-TNFα-IL-17C synergy contributes to the PN-PP transition and disease severity. K5-IL-17C 
and IL-6KO mice were mated and skin inflammation examined. Less severe skin inflammation 
developed in K5-IL-17C-IL-6KO mice vs. K5-IL-17C mice between 10-12 wks of age evidenced by 
less body surface area involvement (P<0.05; n=8/grp); this difference was eliminated by 14 wks of 
age suggesting that cellular and molecular events within the skin compensate for IL-6 absence and 
promote the PN-PP transition. PN skin of 10 and 14 wk old K5-IL-17C-IL-6KO and K5-IL-17C mice 
was compared and decreases in acanthosis, angiogenesis, skin CD4+, CD8+ and F4/80+ cells were 
found at 10 wks (all P<0.04) and were abrogated by 14 wks. Serum TNFα and cutaneous IL-17C, 
IL-36β and IL-36γ were also reduced (~2-5-fold; P<0.05) at 10 wks yet increased significantly at 14 
wks, as did skin-TNFα (3-fold; P=0.003) perhaps compensating for the lack of IL-6. To examine the 
importance of IL-6, primary human KCs were stimulated with IL-6 and significant increases in TNFα, 
IL-17C, IL-36β and IL-36γ (n=6; P<0.05) were observed and increased further when co-stimulated 
with IL-17C ± TNFα. Finally, PN skin of K5-IL-17C-IL-6KO mice reconstituted with intradermal 
IL-6 every other day between 8-10 wks of age had their skin phenotype return to levels similar to 
K5-IL-17C mice. These data demonstrate the ability of IL-17C, TNFα and IL-36 to compensate for 
loss of IL-6 and identify novel signals facilitating the PN-PP transition in psoriasis skin.    
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Nitric oxide releasing nanoparticles effectively prevent Propionibacterium acnes induced 
inflammation by both clearing the organism and inhibiting microbial stimulation of the innate 
immune response
M Qin,1 A Landriscina,2 J Rosen,2 GW Agak,1 S Kao,1 G Wei,1 K Blecher,2 J Bonventre,3 
A Clendaniel,3 J Harper,3 B Adler,2 J Friedman,2 J Nosanchuk,2 J Kim1 and A Friedman2 1 
Medicine (Dermatology), UCLA, Los Angeles, CA, 2 Medicine(Dermatology), Albert Einstein 
College of Medicine, Bronx, NY and 3 EMT, Oregon State University, Corvallis, OR
Acne’s multifactorial etiology, resulting from a mix of hormone-induced elevations in sebum 
production, abnormal follicular epithelial desquamation and proliferation, hypercolonization of 
Propionibacterium acnes and host inflammatory reactions. P. acnes induction of IL-1 cytokines 
through the NLRP3 inflammasome was recently highlighted as a dominant etiological factor for 
Acne Vulgaris. Therefore, therapeutics targeting both the stimulus and the cascade would be ideal. 
Nitric oxide (NO), a potent biological messenger, has documented broad-spectrum antimicrobial 
and immunomodulatory properties. To harness these characteristics to target Acne, we utilized an 
established nanotechnology capable of generating/releasing nitric oxide over time (NO-np). P. acnes 
was found to be highly sensitive to all concentrations of NO-np tested, though human keratinocyte, 
monocyte, and embryonic zebra fish assays revealed no cytotoxicity. NO-np significantly suppressed 
IL-1 β, TNF- α, and IL-6 from human monocytes and IL-6 from human keratinocytes respectively. 
Importantly, silencing of NLRP3 expression by small interfering RNA did not limit NO-np inhibition 
of IL-1 β secretion from monocytes, and neither TNF- α, nor IL-6 secretion nor inhibition by NO-np 
was found to be dependent on this pathway. The mechanism by which NO-np impacts P. acnes 
induced IL-1 β secretion appears to be through inhibition of caspase-1 and IL-1 β gene expression. 
Together, the presented data demonstrating that NO-np have multi-mechanistic antimicrobial and 
anti-inflammatory properties, suggest that NO-np have the potential to serve as a first in class topical 
treatment for acne vulgaris.    
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Intradermal administration of norepinephrine (NE) and adenosine-5’-triphosphate (ATP) 
induces interleukin-6 (IL-6) and CXCL1 expression in murine skin
LL Stohl, W Ding, RD Granstein and JA Wagner Weill Cornell Medical College, New York, NY
We have recently reported preliminary data that repetitive injection of NE and ATP into the skin of 
mice induces an increase in mast cell content of the skin. Several skin disorders, including rosacea 
and psoriasis, are associated with the presence of increased numbers of mast cells and these diseases 
are believed to worsen with stress. In this regard, we hypothesize that release of the sympathetic 
transmitters NE and ATP under conditions of stress may lead to changes in mast cell numbers and, 
perhaps, function with concomitant worsening of skin disease. We have now performed experi-
ments injecting medium alone, 1 μg NE, 32.4 μg ATP or both intradermally into the skin of BALB/c 
mice followed by harvesting of skin at the injected sites, extraction of RNA and performance of 
real-time RT-PCR for proteins of interest. A significant increase in the mRNA levels for IL-6 and the 
chemokine CXCL1 was observed at 1 and 6 hours after injection in the group treated with ATP and 
NE compared to the other groups. Also of interest, NE alone induced a significant increase in the 
mRNA level of vascular endothelial growth factor A (VEGF-A) at 1 and 6 hours after injection. The 
increase in IL-6 expression may be of particular interest as IL-6 enhances mast cell proliferation 
through a fibroblast-mediated mechanism. Although the cellular sources of cytokines in vivo in this 
type of experiment remain to be determined, treatment of murine dermal microvascular endothelial 
cells in vitro with ATP and NE was found to result in enhanced IL-6 release compared to either ATP 
or NE alone. Exacerbation of inflammatory skin disorders by stress might be mediated by release of 
NE and ATP from sympathetic nerves in the skin acting to induce release of inflammatory mediators 
and enhance skin mast cell content.    
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The chronic wound microbiome as a biomarker for clinical outcomes
M Loesche,1 SE Gardner,2 BP Hodkinson,1 A Tyldsley,1 J Horwinski,1 S Boudhar,3 
DJ Margolis1, 3 and EA Grice1 1 Dermatology, University of Pennsylvania, Philadelphia, PA, 
2 School of Nursing, University of Iowa, Iowa City, IA and 3 Biostatistics and Epidemiology, 
University of Pennsylvania, Philadelphia, PA
The development of chronic foot ulcers is a common cutaneous manifestation of diabetes. These 
chronic wounds impose significant medical and economic burdens that may be mitigated by iden-
tification of biomarkers that could improve the evaluation of a patient’s risk profile. To this end, we 
investigated whether the diabetic foot ulcer (DFUs) microbiome was predictive of clinically mean-
ingful outcomes. We collected wound samples from 100 subjects with DFUs every 2 weeks until 
wound closure, amputation, or after 26 weeks of follow-up. The 16S rRNA genes were sequenced 
and used to assess the bacterial load, community composition, and several metrics of diversity 
of the wound microbiome. Using Dirichlet mixture modeling, we clustered samples into distinct 
community types that were associated with wound outcomes and clinical factors. We generated 
logistic regression models adjusted for several clinical factors to identify microbiome features that 
are associated with wound healing and development of complications. While the microbiome had 
no effect on healing, we found that increased wound diversity reduced the odds of developing a 
complication, whereas increased levels of Streptococcaceae increased complication odds. These 
results suggest that the chronic wound microbiome may be used as a prognostic biomarker for 
clinically meaningful outcomes.    
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Targeting tumor-associated macrophages with anti-CSF-1R antibodies as a strategy for inhib-
iting T cell lymphoma tumorigenesis
S Hwang, X Wu and Y Imai Dermatology, Medical College of Wisconsin, Milwaukee, WI
Tumor-associated macrophages (TAMs) are specifically induced within the tumor microenvironment 
and may regulate tumor proliferation and angiogenesis. We reported a tumor-promoting M2-like 
phenotype for TAMs isolated from xenografted CTCL tumors in immunodeficient NSG mice. Deple-
tion of TAMs in CTCL tumors by clodronate-liposomes effectively blocked tumor growth, suggesting 
that macrophages may play a role in tumorigenesis. Herein, we asked if CS7, a monoclonal anti-
mouse colony stimulating factor receptor-1 antibody that blocks macrophage differentiation and 
proliferation, has an impact on T cell lymphoma tumorigenesis. We assessed tumor size by direct 
measurement after implantation of murine MBL2 T lymphoma cells in the flanks of NSG mice and 
immune cell alteration by flow cytometry. Intraperitoneal administration of CS7 3 times a week in 
mice resulted in decreased numbers of macrophages in the spleen, but did not affect T and B cell 
numbers. In the MBL2 tumor model, CS7 treatment effectively decreased the tumor sizes when 
compared to control IgG (63.6 vs 161.2 mm2, p<0.0001, n=8). Assessment of TAMs in tumors 
revealed that CD11b+F4/80+ macrophages were decreased more than 3-fold by CS7 treatment. In 
addition, CD11b+Ly-6C+ monocytes were decreased to a similar degree. CD11b+Ly-6G+ neutrophils, 
however, were not impacted by CS7 treatment. Fluorescence immunostaining of tumor sections 
showed that expression of CD31, but not PDPN, was decreased in tumors that were treated by CS7, 
suggesting that reduction of macrophages may lead to decreased angiogenesis within tumors. These 
results demonstrate that agents targeting macrophage differentiation and/or proliferation inhibit T 
cell lymphoma growth. Since we observed a reduction in angiogenesis in CS7 treated tumors, we 
speculate that that the lack of macrophages in the CS7-treated tumors results in reduced levels of 
VEGF-A, a product of M2 TAMs. Our studies suggest that alteration of the immune cell environment 
can effectively help control the growth of aggressive T cell lymphoma in a preclinical model.   
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Commensal microbiota-responsive basophils promote atopic dermatitis-associated itch
LK Oetjen1, 2, C Guo2, 3, MR Mack1, 2, TM Whelan1, 2, Q Liu2, 3 and BS Kim1, 2 1 Division of 
Dermatology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, 
MO, 2 Center for the Study of Itch, Washington University in St. Louis, St. Louis, MO and 3 
Department of Anesthesiology, Washington University in St. Louis, St. Louis, MO
The central and most debilitating symptom in patients with atopic dermatitis (AD) is pruritus, which 
leads to scratching and skin barrier disruption. Recent studies have shown that alterations in com-
mensal microbiota are associated with flares in AD disease. In addition, we have identified that an 
accumulation of basophils in the skin is associated with the presence of AD in patients and is critical 
for the progression of AD-like disease in mice. However, whether commensal microbiota influence 
cutaneous basophil responses and pruritus in AD remains poorly defined. In this study, employing 
a well-established model of AD-like disease associated with cutaneous basophilia, we identify a 
robust induction of pruritus in mice. Strikingly, we identified that basophils promote pruritus in 
the context of AD-associated inflammation. Finally, mice treated with systemic broad spectrum 
antibiotics demonstrated increased influx of basophils into lesional AD-like skin associated with 
elevated IL-4, IL-13, and IgE production compared to conventional mice. Collectively, these studies 
reveal a previously unrecognized commensal-basophil-pruritus axis in the context of AD-associated 
inflammation that holds high promise as a therapeutic target in patients.    
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Three-dimensional printing of chemotherapeutic and antibiotic eluting fibers, seeds, and discs 
for localized drug delivery in cutaneous disease
JA Weisman1, 2, NM Kaskas,1 AH Green,1 DH Ballard,1 JJ Ambrose,2 L Sun2 and DK Mills2 1 
Louisiana State University School of Medicine, Shreveport, LA and 2 Biomedical Engineering, 
Louisiana Tech University, Ruston, LA
Additive manufacturing methods (such as 3D printing) have the potential to be used for personalized 
medicine in dermatology. The purpose of our study was to show that bioactive constructs can be 
3D printed using adsorbable bioplastics that contain antibiotics or chemotherapeutics for a local-
ized and sustained drug delivery at the level of the integument. Many current research projects are 
focusing on localized drug delivery alternatives to systemic drug treatments in cutaneous infectious, 
oncologic, and inflammatory pathology. A method of extruding bioactive 3D printer filaments was 
developed and used in fused deposition modeling printers to create bioactive constructs loaded 
with gentamicin or methotrexate. Gentamicin-laden 3D fabrication was done using a resolution 
of 200 to 400 microns of: 30 mm lengths to act as fibers, 5 mm lengths to act as seeds, and 6 mm 
diameter round discs. Each category of construct consisted of five control and five 2.5 wt% genta-
micin-laden constructs. Gentamicin-laden constructs were tested on both Mueller-Hinton bacterial 
plates and broth cultures with E. coli bacteria. To test the potential for targeted oncological therapy, 
2.5 wt% methotrexate-laden constructs were fabricated as 10 mm filaments and were tested in 
tumor cell cultures. Only gentamicin-laden constructs showed bacterial growth inhibition. Only 
methotrexate-laden constructs showed tumor cell growth inhibition. This is the first study to use 
additive manufacturing methods to 3D print bioactive constructs and fibers with the potential to 
treat a variety of dermatologic disease.    
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C. elegans as a model to screen natural human odors produced by the human skin microbiome
S Wang1 and C Huang1, 2 1 Life Sciences, National Central University, Taoyuan, Taiwan and 
2 University of California, San Diego, CA
Caenorhabditis elegans (C. elegans) was used as a model to screen the attractant and repellent odors 
produced naturally by microbes in the human skin microbiome. By nuclear magnetic resonance 
(NMR) analysis, we have demonstrated that skin commensal bacteria (eg. Staphylococcus epider-
midis and Propionibacterium acnes) can exploit the glycerol, an endogenous sugar found in human 
skin, as a carbon source to produce short-chain fatty acids (SCFAs) via fermentation. Production 
of SCFAs on the skin can contribute to the human odors. C. elegans has a highly developed che-
mosensory system that enables it to sense a wide variety of SCFAs. Three SCFAs (acetic, butyric, 
and propionic acids), butanone (a known C. elegans attractant) and trans-10, cis-12 conjugated 
linoleic acid (CLA) produced by Propionibacterium acnes are used in this study. C. elegans were 
place at a site 1 cm away from the 10 μM butyric acid, propionic acid, CLA or its controls. The 
warms move randomly to all directions, suggesting that butyric acid, propionic acid and CLA are 
neither attractants nor repellents for C. elegans. In contrast, when acetic acid and butanone were 
spotted at a site of plates, C. elegans migrated towards these chemicals, indicating that acetic acid 
is an attractant for C. elegans. Establishment of C. elegans migration assays provides a screening 
tool for identification of natural attractants and repellents derived from the human skin microbiome.   
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Reducing flightless I expression decreases severity of psoriasis in an imiquimod-induced 
murine model 
Z Kopecki,1 H Chong,1 G Yang,1 S Sidhu,2 J Ibbetson3 and A Cowin1 1 University of South 
Australia, Adelaide, SA, Australia, 2 Royal Adelaide Hospital, Adelaide, SA, Australia and 3 
South Australian Pathology, Adelaide, SA, Australia
Psoriasis is a common chronic skin condition characterised by excessive inflammation and aberrant 
epidermal proliferation. The actin remodelling protein, Flightless I (Flii) can regulate tissue inflam-
mation via its effects on toll-like receptor signalling. Here we identify Flii as a novel target involved 
in psoriasiform dermatitis. Biopsies of psoriatic skin lesions from patients showed elevated levels 
of Flii compared to normal human skin and Flii expression was observed in the spinous zone of the 
epidermis. Psoriasis-like lesions were induced in Flii heterozygous (Flii+/-), wild-type (Flii+/+) and Flii 
transgenic (FliiTg/Tg) mice using topical application of imiquimod. Reducing Flii decreased erythema, 
reduced inflammatory cell infiltrate and decreased the thickness of the epidermis compared to wild-
type and FliiTg/Tg mice. Reduced expression of pro-inflammatory cytokines including IL-17A, NF-B 
and TNF-α were observed in the psoriasis-like lesions of Flii+/- mice. In contrast, significantly ele-
vated inflammation was noted in skin of wild-type and FliiTg/Tg mice including increased epidermal 
hyperplasia, dermal cellular infiltrate and mRNA levels of IL-17A, IL-22, IL-23 and TNF-α cytokines. 
Topical application of Flii neutralising antibodies to wild-type mice treated with imiquimod resulted 
in significantly reduced epidermal hyperplasia, erythema and inflammation, suggesting that reducing 
cutaneous Flii could be a potential new approach for treating patients with psoriasis.    
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Probiotic activity of S. epidermidis in the skin microbiome inhibits the growth of T. rubrum: 
A fungal nail treatment
H Tsou,1 P Yu,1 S Marito1 and C Huang1, 2 1 Taiwan National Central University, Taoyuan, 
Taiwan and 2 University of California, San Diego, CA
Dermatophytes are a type of fungal infections on nails. Trichophyton rubrum (T. rubrum) causes 
over 90% of dermatophytes in humans. By nuclear magnetic resonance (NMR) analysis, we demon-
strate that Staphylococcus epidermidis (S. epidermidis), a commensal bacterium in the human skin 
microbiome, can mediate the fermentation of glycerol to produce short-chain fatty acids (SCFAs). To 
examine if S. epidermidis fermentation affects the growth of T. rubrum, the S. epidermidis bacteria 
were grown on agar plates in the presence or absence of glycerol, a naturally occurring metabolite 
found in human skin, right before growing T. rubrum in the overlaid agar. Only S. epidermidis grown 
with glycerol showed visible inhibitory effects against T. rubrum, suggesting that S. epidermidis 
exploits the glycerol fermentation against T. rubrum. Butyric acid, one of SCFAs in the fermented 
media, effectively suppresses the growth of T. rubrum. Co-incubation of human nail plates with 
S. epidermidis and T. rubrum in the presence of glycerol significantly reduces the growth of T. 
rubrum. Inoculation of butyric acid onto human nails may be unable to yield a pharmacologic/
effective concentration due to its short-half in skin. A butyric acid analog is synthesized to circum-
vent this problem. The butyric acid analog hinders the growth of T. rubrum in a dose-dependent 
manner. Our study introduces and validates a novel mechanism in which skin commensal bacteria 
undergo fermentation to ward off the fungal infection. The mechanism will lead to new strategies 
for treatments of T. rubrum-associated skin diseases inducing tinea capitis, tinea corporis, and deep 
dermal T. rubrum infections.    
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Type 2 human papillomavirus E7 can attenuate NF-κB in human epidermal keratinocytes
Y Ryu,1 J Han,1 J Lee,1 S Choi2 and Y Park1 1 Seoul St. Mary’s Hospital, Seoul, Korea (the 
Republic of) and 2 Han Nam University, Daejeon, Korea (the Republic of)
Human papillomavirus (HPV) is composed of 6 early genes (E1, E2, E4, E5, E6 and E7) and 2 late 
genes (L1 and L2). Although HPV E7 in high risk types is known to be oncogenic, the role of E7 in 
low risk types is not clearly understood. In this study, we investigated whether E7 of low risk HPV 
can attenuate nuclear factor-kappa B (NF-κB), which result in little inflammation found in common 
wart lesions. Wart tissues were used for immunohistochemistry and real time PCR. Type 2 HPV E7 
was transfected in normal human keratinocytes (NHK) for luciferase assay and immunofluorescence. 
E7 and TLR9 were co-expressed in the granular layer in which viral infected cells were aggregated. 
TLR9 mRNA expression of E7 transfected cells was significantly increased, compared to that of 
empty vector transfected cells (p<0.05). NF-κB luciferase activity and p65 nuclear translocation of 
E7 transfected cells were significantly decreased, compared to those of empty vector transfected 
cells (p<0.05). Increased NF-κB activities were significantly inhibited by E7 siRNA (p<0.05). Based 
on our results, we suggest that inhibition of the NF-κB activation by E7 of low risk HPV might 
contribute to little inflammation in common warts and reactivation of NF-κB might be a potential 
therapeutic target for them.    
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Signaling through tachykinin receptors regulates the pro-inflammatory and type 2-biasing 
functions of mast cells
TL Sumpter,1 O Tkacheva,1 W Schufesky,4 A Morelli4 and AT Larregina1, 2, 3 1 Dermatology, 
University of Pittsburgh, Pittsburgh, PA, 2 Immunology, University of Pittsburgh, Pittsburgh, 
PA, 3 McGowen Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 
and 4 Surgery, University of Pittsburgh, Pittsburgh, PA
Mast cells (MCs) are skin-resident immune sentinels which accumulate in allergic disease, like 
atopic dermatitis (AD). MCs are activated via interactions between the FcεRI and IgE-Ag complexes 
in the course of allergic reactions. IgE-activated MCs release preformed and de novo transcribed 
pro-inflammatory and type 2 skewing cytokine. As such, MCs sustain innate and adaptive immune 
responses in allergic disease. In the skin, MCs reside proximal to neurons. MCs and neurons may 
have evolved common mechanisms present in their shared microenvironment to counteract noxious 
stimuli, including responsiveness to neuropeptides. However, studies delineating the function of 
neuropeptides in MC responses, particularly those initiated by FcεRI are lacking. Here, we addressed 
the role of neuropeptide-initiated signaling on MC function, in vivo and in vitro, focusing on tachy-
kinin receptors, the neurokinin -1 receptor (NK1R) and NK2R. We demonstrate a pro-inflammatory 
role for NK1R signaling in vivo, amplifying IgE-initiated responses in murine models of cutaneous 
and systemic anaphylaxis. In vitro, FcεRI ligation of bone marrow derived (BM)MCs from wild-type 
(WT) mice increased NK1R and NK2R protein levels and released the tachykinin agonist, hemoki-
nin-1. NK1R-/- BMMCs had impaired TNF-α, IL-6 -4 and -13 release which was linked to impaired 
Akt-dependent NFκB activation. In contrast, inhibition of NK2R signaling with the antagonist, 
GR 159897 increased cytokine release in WT BMMCs. We conclude that coordinated signaling 
through the NK1R and the NK2R define a FcεRI-initiated feedback loop, implicating neuropeptides 
in IgE-mediated anaphylactic and atopic disorders, including AD.    
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Microbiome study with an in vitro reconstructed skin
L Valla-Dury,1 C Lebeux,2 V Cenizo,2 V Andre-Frei,2 S Leoty-Okombi,2 A Vianney1 and 
S Cadau2 1 CIRI, Univ Lyon, Lyon, France and 2 BASF Beauty Care Solutions, Lyon, France
Acne vulgaris is a skin disease. The role of the commensal bacteria Propionibacterium acnes in this 
pathology has been further investigated demonstrating its association with the progression of the 
disease. Unlike to P. acnes, another commensal bacteria, Staphylococcus epidermidis, is known 
for its beneficial contribution for an healthy skin. Nowadays, no 3D model exists to study the skin 
microbiome. For this purpose BASF tried to define the best conditions for the introduction of S. 
epidermidis and P. acnes in an artificial skin model and thus creating a model for screening mole-
cules of cosmetic interest. The colonization of the two species, alone or together, on reconstructed 
epidermis and reconstructed skin was evaluated: the bacterial adhesion and development efficiency 
was estimated using the colony forming unit (CFU) assay after the recovery of bacteria from artificial 
tissues. The presence of S. epidermidis and P. acnes, as well as their effect on the epidermal and 
dermal cells on reconstructed skin has been visualized by microscopy. Our results showed that S. 
epidermidis and P. acnes are able to colonize efficiently reconstructed epidermis and reconstructed 
skin. There is no competition between the 2 bacteria during the adhesion phase. However, it has 
been shown that S. epidermidis may slightly inhibit the growth of P. acnes. Microscopic visualisation 
revealed no harmful impact of the colonization of the 2 bacteria on reconstructed skin and generally 
the 2 bacteria were found in the stratum corneum or at the epidermis surface of less differentiated 
skin. Finally, this model was used to screen several active ingredients to study their effects on the 
growth of P. acnes and S. epidermidis. Among them, one shows very interesting results as it promotes 
the growth of S. epidermidis compared to P. acnes. To our knowledge this model is the first proof 
of concept that cutaneous flora can be studied in vitro. Qualitative and quantitative results were 
obtained and its functionality validated through an active ingredient which changed bacteria ratio.   
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Cell-specific inflammatory response to short-chain fatty acids produced by P. acnes
JA Sanford and RL Gallo Dermatology, University of California, San Diego, San Diego, CA
Propionibacterium acnes is a skin-resident bacterial species that is commonly associated with acne. 
Previous work has shown that P. acnes produces ligands for TLR2 that trigger cytokine release 
from keratinocytes and monocytes. However, normal skin tolerates abundant P. acnes and TLR2 
ligands without evidence of inflammation. We hypothesized short-chain fatty acids (SCFAs) made 
by P. acnes may be a factor in regulating the inflammatory response. We first confirmed that P. 
acnes produced abundant amounts of SCFAs under conditions favoring anaerobic fermentation, a 
condition likely to occur in occluded sebaceous glands. In agreement with published literature in 
monocytes and macrophages, we found that the SCFAs propionate and butyrate strongly inhibited 
TLR2/6-mediated production of the pro-inflammatory mediators IL-6 (4.9 and 18.9-fold decrease, 
p<0.0001) and TNFα (1.9 and 1.6-fold decrease, p<0.001) from bone marrow-derived dendritic 
cells (BMDCs). However, human epidermal keratinocytes (HEKs) showed an increased response 
to TLR2/6 activation when treated with equivalent concentrations of propionate or butyrate, with 
increases in the transcription and secretion of IL-6 (3.1 and 2.5-fold increase, p<0.01) and IL-8 (2.8 
and 1.7-fold increase, p<0.05). Since butyrate is a known inhibitor of histone deacetylase enzymes 
we tested if the cell-specific inflammatory response to SCFAs by keratinocytes was due to an epi-
genetic influence on histone acetylation. However, siRNA mediated depletion of the class I histone 
deacetylases HDAC1, HDAC2, and HDAC3 in HEKs had an opposite effect to butyrate, decreasing 
secretion of IL-6 (1.6-fold, p<0.01) and IL-8 (1.4-fold). Thus, the impact of SCFAs on keratinocyte 
cytokine production may not be due to their effect on HDAC activity but rather due to cell specific 
receptors for these fatty acids. Our findings suggest that conditions that promote SCFA production 
by P. acnes may be a key event in transformation of the organism from a non-inflammatory skin 
commensal to the pathogenic trigger of inflammatory acne.    
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PD-1 regulates imiquimod-induced psoriasiform dermatitis through inhibition of innate 
IL-17A expression by γδ low T Cells
Y Imai,1 X Wu,1 N Ayithan,2 L Wang2 and S Hwang1 1 Dermatology, Medical College of 
Wisconsin, Milwaukee, WI and 2 Microbiology and Molecular Genetics, Medical College of 
Wisconsin, Milwaukee, WI
Programmed cell death 1 (PD-1) is a regulatory receptor on immune cells that has been targeted in 
cancer immunotherapy with clinical success. Psoriasis-like skin inflammation has been reported in 
clinical trials using agents that specifically inhibit PD-1, suggesting that PD-1 may regulate psoriatic 
inflammation in skin. To determine if PD-1 regulates psoriasiform dermatitis, we compared histo-
logic and cytokine responses in the skin of PD-1-deficient (PD-1KO) mice and wild type controls 
(WT) in an imiquimod (IMQ)-induced murine model of psoriasis. At limiting concentrations of topi-
cally applied IMQ, PD-1KO mice revealed marked epidermal hyperplasia and striking neutrophilic 
infiltration into the epidermis whereas WT mice showed only subtle psoriatic changes. Enhanced 
inflammatory changes in skin were also observed when WT mice were treated anti-PD-1 neutral-
izing antibodies and IMQ. Messenger RNA expression of IL-17A, IL-22, CXCL1, and CXCL2 were 
increased in the IMQ-treated skin of PD-1KO mice. PD-1 expression on gamma-delta (γδ) low (GDL) 
T cells in the skin of IMQ-treated mice was elevated to high levels by exposure to IMQ, which also 
increased expression of the PD-1 ligand, PD-L1, in keratinocytes. Two- and four-fold increases in the 
percentage of IL-17A+ GDL T cells from the skin and lymph nodes, respectively, were observed in 
skin cell suspensions derived from IMQ-treated PD-1KO mice compared to WT controls, suggesting 
that the lack of PD-1 has a functional effect on GDL T cells that express Th17 cytokines. These 
results provide an immunological mechanism for the clinical observation of psoriatic inflammation 
in patients treated with a PD-1 antagonist and suggest that PD-1 potentially regulates innate immune 
cells such as GDL T cells in the setting of autoimmune skin diseases such as psoriasis.    
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Secrets from the past: Natural products and the future of topical anti-infectives
CL Quave1, 2, J Lyles,2 K Nelson,1 JS Kavanaugh,3 C Parlet,3 H Crosby3 and A Horswill3 1 
Dermatology, Emory University School of Medicine, Atlanta, GA, 2 Center for the Study of 
Human Health, Emory University, Atlanta, GA and 3 Microbiology, University of Iowa Roy 
and Lucille A. Carver College of Medicine, Iowa City, IA
The Mediterranean is home to a rich history of medical traditions that have developed under the 
influence of diverse cultures over millennia. Today, many such traditions are still alive in the folk 
medical practices of local people. Investigation of botanical folk medicines used in the treatment 
of skin and soft tissue infections (SSTIs) in southern Italy led us to the discovery of a suite of natural 
product inhibitors of the Staphylococcus aureus accessory gene regulator (agr) system. Inhibi-
tion of bacterial communication blocks production of myriad virulence factors (e.g. delta-toxin, 
alpha-toxin, phenol soluble modulins) responsible for host tissue damage and impairment of host 
immunity during infection. Bioassay-guided fractionation techniques were used in the isolation of 
a refined fraction (224C-F2) containing several bioactive natural products. Quorum quenching was 
detected through use of agr::P3 reporters and confirmed in each of the four agr types. Moreover, 
additional supporting data was generated through HPLC quantification of delta-toxin, MIC testing, 
red blood cell lysis testing, assessment of supernatant damage to human keratinocyte (HaCat) cells, 
and a murine skin abscess model. Importantly, our findings include evidence of specific S. aureus 
anti-virulence activity in the absence of growth inhibition, as well as a lack of inhibition of normal 
skin commensals (e.g. S. epidermidis, Micrococcus luteus and Corynebacterium spp.) This work 
not only offers compelling evidence in support of the traditional use of this species to treat SSTIs, 
but also provides us with a new set of small molecule inhibitors for further study.    
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Psoriasin (S100A7) regulates markers of epidermal differentiation
A Ekman, J Vegfors, C Bivik and C Enerbäck Ingrid Asp Psoriasis Research Center, Linköping 
University, Linköping, Sweden
Psoriasis is characterized by epidermal hyperproliferation and a disturbed differentiation process. 
The maturation pathway of keratinocytes in active psoriatic lesions differs from that of the normal 
epidermis and an altered sequence of expression of differentiation markers has been described 
in psoriasis. So far the mediators that are responsible for this altered differentiation of psoriatic 
keratinocytes have not been identified. Psoriasin (S100A7), a member of the S100 family of calci-
um-binding proteins, is highly expressed in psoriatic keratinocytes. In addition to the high expression 
in the psoriatic epidermis, psoriasin is also expressed in other conditions that display abnormal cell 
differentiation. The aim of this study was to investigate the involvement of psoriasin in keratino-
cyte differentiation. Using immunohistochemistry we found a marked psoriasin expression in the 
psoriatic epidermis. The expression formed a gradient, ranging from a weak staining in the basal 
layer to an intense staining in the more differentiated suprabasal layers. To investigate whether 
psoriasin is induced in the differentiation process, human epidermal keratinocytes (HEKn) were 
treated with the differentiation-promoting stimuli CaCl2 and PMA. Both these treatments gave rise 
to morphological changes, an upregulation of the differentiation marker involucrin and an increased 
production of psoriasin. Inhibition of the PKC pathway reduced the expression of both psoriasin 
and involucrin. Treatment with CaCl2 also triggered the induction of the differentiation markers 
filaggrin, desmoglein 1, desmocollin 1, transglutaminase 1 and CD24. Downregulation of psoriasin 
using siRNA resulted in a decreased expression of involucrin, desmoglein 1, translutaminase 1 and 
CD24, suggesting that psoriasin may be involved in the regulation of these markers. In summary, 
these data suggest that psoriasin upon upregulation in response to differentiation-inducing stimuli 
in turn may regulate the expression of several differentiation markers and may influence the kera-
tinocyte differentiation process.    
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Inhibition of adhesion proteins expression in human dermal microvascular endothelial cells 
exposed to TNF-α by a Sambucus nigra extract
M Frechet,1 L Valenti,2 P Markioli,2 P Lafitte,1 F Maccario2 and J Nicolay1 1 Exsymol, Monaco, 
Monaco and 2 Sedifa Laboratoire, Monaco, Monaco
Chronic stress (UV, pollution, infection…), and aging result in local inflammation, which is char-
acterized by a vasculature remaining activated, enlarged and hyperpermeable. Therefore, plasma 
and blood cells extravasate in the surrounding tissue, provoking the accumulation of fluid leading 
to the development of unaesthetic oedema. Early inflammatory signaling involves pro-inflamma-
tory cytokines released by keratinocytes (the most exposed cells). These mediators are decisive in 
modulating the cellular communication that enables dermal and in particular endothelial cells to 
participate in inflammatory responses. Activation of the TNF-α receptor at the surface of endothe-
lial cells leads to the induction of nuclear factor κB (NFκB) signaling pathway that were shown to 
involve iron ions (Fe2+) and reactive oxygen species. Finally, this activation results in the expression 
of adhesion proteins as vascular cellular adhesion molecule 1 (VCAM-1) and intercellular adhesion 
molecule 1 (ICAM-1) in the luminal face of the blood vessel, which mediates the extravasation. 
To identify efficient ingredients against skin inflammation, we have set up a three steps in vitro 
screening procedure: 1- measurement of antioxidant and iron chelating properties 2- monitor-
ing of the inhibition of adhesion proteins VCAM-1 and ICAM-1 expression in TNF-α stimulated 
human dermal microvascular endothelial cells (HDMEC) 3- monitoring of monocytes adhesion to 
TNF-α stimulated HDMEC. An extract from Sambucus nigra flowers endowed with good antioxidant 
and iron chelating properties was the most active inhibitor of VCAM-1 and ICAM-1 expression, 
and strongly reduced monocytes adhesion to TNF-α stimulated HDMEC. Hence, this extract may 
improve some inflammatory skin conditions, and may thus prevent the hemodynamic congestion 
common in erythema, dark circles or rosacea.    
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Coincident therapeutic light plus ultrasound for P. acnes and S. aureus biofilm eradication
TB McNeely, M Schafer and A Dakin R&D, PhotoSonix Medical Inc., Ambler, PA
Biofilms are highly resistant to antibiotics and the immune system, making them difficult to treat 
at best, and nearly impossible to eradicate at worst. Biofilms have been implicated in the etiology 
of both severe acne vulgaris and atopic dermatitis. With limited treatment options for biofilm 
infections, alternative methods were investigated. A combination of two low level energies was 
explored for therapeutic effect. This new energy based technology is termed CLENS™ (Coincident 
Light Energy and Non-focused ultraSound). A laboratory prototype was built which produces both 
low intensity ultrasound and light uniformly and coincidently from a single treatment head. To 
demonstrate proof of concept, P. acnes and S. aureus biofilms were cultured on Millicell hanging 
inserts placed in 6-well tissue culture plates. For treatment investigations, biofilm (4-7 days old) in 
hanging inserts was submerged in saline below the treatment head. After exposure, bacteria killing 
was quantified by serial dilution and plating on media agar. Killing was dose dependent on exposure 
time, and could be optimized with tuning of either the light or ultrasound energy. There was >1 
log10 reduction after 5 min and >3 log10 reduction after 30 min treatment (p<0.05). In comparison, 
24 hr exposure to erythromycin reduced biofilm CFU by less than 1 log10 (p<0.05). While a 30 min 
CLENS treatment induced significant bacterial death the die off continued to 24 hr after exposure 
with an additional 2 log10 reduction (p<0.05). Biofilm regrowth started at 48 hr, but after 4 additional 
days of growth, the biofilm had not returned to the original CFU levels (p<0.05). Importantly, the 
two energies must be delivered coincidentally for optimal effect. The dual energies of CLENS are 
within the limits considered safe by the FDA. CLENS is the first reported dual energy-based method 
of treating bacterial biofilms, and is being developed as a safe, efficacious, non-pharmacological 
treatment approach for acne vulgaris and atopic dermatitis.    
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Improved understanding of the mechanistic aspects of skin allergy – studies of the fluorescent 
contact sensitizer TRITC
I Karlsson,1 K Samuelsson,2 C Simonsson,2 L Ilag,1 C Jonsson,2 A Karlberg2 and U Nilsson1 
1 Department of Analytical Chemistry, Stockholm University, Stockholm, Sweden and 2 
Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, 
Sweden
Contact allergy is a chronic condition that affects as many as 20% of the western population. The 
immunological mechanism of skin allergy has been extensively studied and it is known that a 
compound has to penetrate the skin and modify skin proteins to cause contact allergy. However, 
many aspects of this unwanted side effect of our immune system still remain unknown. For instance, 
where in the skin and lymph nodes this protein modification takes place or which cells and proteins 
that are being targeted are mostly unknown. In this project we have utilized the fluorescent contact 
sensitizer TRITC to provide answers to these fundamental mechanistic aspects of skin allergy. To 
study the distribution of TRITC in vivo, mouse ears were painted with TRITC and examined with 
laser confocal microscopy (LSCM). TRITC was detected mainly in stratum corneum, hair follicles, 
and in the matrix of the cartilage. LSCM analysis of lymph node sections showed TRITC scattered 
throughout the lymph node. Flow cytometry analysis of lymph node single cell suspensions showed 
that 70% of the cells were fluorescent, which can be compared to only 2% of the cells in the control 
group. The obtained results demonstrate that TRITC-bound immunogenic complexes are formed and 
transported to the local lymph nodes. Chemical reactivity experiments of TRITC toward peptides 
reveled that TRITC reacts rapidly with cysteine residues. However, these adducts are unstable and 
as the TRITC-cysteine adducts degrade, stable TRITC-lysine adducts are formed instead. We believe 
that the initial adduct formation with cysteine has two important functions in the induction of 
contact sensitization. First, degradation of very reactive haptens are prevented by adduct formation 
with cysteine. Second, the hapten-conjugation with cysteine enables transport of the haptens into 
epidermis where they can form stable adducts with lysine and thus induce an immune response.   
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Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded 
dissolvable microneedle arrays
G Erdos,1 E Korkmaz,2 E Friedrich,3 M Ramadan,4 AR Mathers,1 B Ozdoganlar,2 N Washburn3 
and LD Falo1, 6, 5 1 Dermatology, Univ. of Pittsburgh School of Medicine, Pittsburgh, 
PA, 2 Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA, 3 Biomedical 
Engineering, Carnegie Mellon University, Pittsburgh, PA, 4 Chemistry, Carnegie Mellon 
University, Pittsburgh, PA, 5 Bioengineering, University of Pittsburgh, Pittsburgh, PA and 
6 Clinical and Translational Science Institute, Univ. of Pittsburgh School of Medicine, 
Pittsburgh, PA
Tumor necrosis factor-alpha (TNF-a) specific antibodies (anti-TNF-a Ab) have been shown to be 
potent TNF inhibitors and effective therapeutics for a range of inflammatory diseases. Typically, these 
drugs are administered systemically, but systemic dosing sufficient to achieve locally effective con-
centrations in peripheral tissues has been associated with systemic immunosuppression and related 
adverse events. Here, we evaluated the use of tip-loaded dissolvable microneedle arrays (MNAs) 
for localized intradermal delivery of anti-TNF-a Ab. MNAs with obelisk shape microneedles that 
incorporate the antibody cargo in the needle tips were created from carboxymethylcellulose (CMC) 
using a micromilling/spin-casting fabrication method. We found that Anti-TNF-a Ab integrated into 
MNAs using this room temperature fabrication process maintained conformationally dependent 
TNF-a binding activity. Further, these MNAs efficiently delivered anti-TNF-a antibodies to the 
dermis of human skin with clinically applicable release profiles and pharmacokinetics. To evaluate 
MNA delivered anti-TNF-a Ab function, we applied anti-TNF-a Ab containing MNAs to established 
psoriasiform lesions on the skin of mice. MNA anti-TNF-a Ab treatment reduced key biomarkers 
of psoriasiform inflammation including epidermal thickness and IL-1β expression. Taken together, 
these results demonstrate efficient and biologically effective MNA delivery of anti-TNF-a Ab to the 
intradermal microenvironment of the skin in mice and humans, and support the development of 
MNA mediated antibody delivery for clinical applications.    
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Interferon-gamma enhances TLR3 expression and anti-viral activity in keratinocytes
S Morizane,1 A Kajita,1 T Takiguchi,2 T Yamamoto,3 M Yamada4 and K Iwatsuki1 
1 Dermatology, Okayama University Graduate School of Medicine, Dentistry and 
Pharmaceutical Sciences, Okayama, Japan, 2 Plastic Surgery, Hamamatsu University School 
of Medicine, Hamamatsu, Japan, 3 Dermatology, Kawasaki Medical School, Kurashiki, 
Japan and 4 Virology, Okayama University Graduate School of Medicine, Dentistry, and 
Pharmaceutical Sciences, Okayama, Japan
Toll-like receptors (TLRs) recognize specific microbial products in the innate immune response. 
TLR3, a double-stranded RNA sensor, is thought to play an important role in viral infections, but 
the regulation of TLR3 expression and its function in keratinocytes are not fully understood. Here 
we show the Th1 cytokine IFN-γ (2 ng/ml) increased the TLR3 expression (76.7-fold, p<0.05) via 
STAT-1 in cultured normal human epidermal keratinocytes (NHEKs). Co-stimulation with IFN-γ (2 
ng/ml) and the TLR3 ligand poly (I:C) (0.1 μg/ml) synergistically increased the expression of IFN-β 
(42.6-fold, p<0.001), IL-6 (6,763-fold, p<0.001), IL-8 (91.3-fold, p<0.001) and human β-defensin-2 
(884.4-fold, p<0.001) in NHEKs compared to poly (I:C) or IFN-γ alone. These synergistic induc-
tions were significantly inhibited by an endosomal acidification inhibitor, chloroquine (50 μg/ml, 
p<0.001), and by TLR3 siRNA (p<0.01). Co-stimulation with IFN-γ and poly (I:C) also significantly 
enhanced the anti-viral activity against herpes simplex virus type-1 in NHEKs compared to poly (I:C) 
(p<0.001) or IFN-γ alone (p<0.001). In addition to the in vitro findings, an immunohistochemical 
analysis revealed IFN-γ-positive cells surrounding herpetic vesicles. These findings indicate that 
IFN-γ might contribute to the innate immune response to cutaneous viral infections by enhancing 
TLR3 expression and function in keratinocytes.    
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IL-1 and IL-36 are the dominant cytokines in generalized pustular psoriasis
A Johnston,1 X Xing,1 L Wolterink,1 DH Barnes,1 WR Swindell,1 MK Sarkar,1 JM Kahlenberg,2 
PW Harms3 and JE Gudjonsson1 1 Dermatology, Univ. of Michigan, Ann Arbor, MI, 2 
Rheumatology, Univ. of Michigan, Ann Arbor, MI and 3 Pathology, Univ. of Michigan, Ann 
Arbor, MI
Generalized pustular psoriasis (GPP) is a rare debilitating and often life-threatening, inflammatory 
disease characterized by episodic infiltration of neutrophils into the skin, pustule development, and 
systemic inflammation. This condition can manifest in the presence or absence of chronic plaque 
psoriasis (CPP). Current treatments are unsatisfactory and a better understanding the pathogenesis of 
GPP may yield new therapeutic approaches. To assess the pathophysiological differences between 
GPP and chronic plaque psoriasis (CPP) we analyzed archived formalin-fixed paraffin-embedded 
biopsies of confirmed GPP (n=20) and CPP (n=12) cases and healthy control (n=12) skin using 
Affymetrix Human Gene ST 2.1 arrays. Compared with healthy skin, GPP lesions yielded 861 
and CPP 779 differentially expressed genes (>2-fold change, p<0.05) with 269 of these transcripts 
upregulated in both diseases. Using qRT-PCR we detected significantly higher expression of IL36A 
(3-fold, p=0.015) and IL36G (4-fold, p=0.05) in GPP than CPP respectively, whereas expression of 
IL36RN was equivalent. Likewise, IL1B was 11 times more abundant in GPP than CPP (p=0.005), 
with equivalent expression of IL1RN in the 2 diseases. This was accompanied by increases in 
neutrophil chemokines CXCL1, CXCL2 and IL8 (15-, 3-, and 20-fold greater mRNA expression in 
GPP than CPP respectively, p<0.05, all). These data were confirmed by IHC, and indicate a level of 
sustained activation of the IL-36 and IL-1 systems in GPP, which drive neutrophil infiltration. Sug-
gesting a departure from typical Th1/Th17 pathophysiology, IL23A, IL17A, IFNG, CXCL9, CXCL10 
and MX1 expression were found to be significantly lower in GPP compared to CPP (p<0.01 all). In 
summary, our data may have major therapeutic implications as they suggest that the IL-1 and IL-36 
inflammatory axes are the main drivers of disease pathology in GPP, and question the contribution 
of IL-17 and/or IFN-γ to its pathogenesis.    
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The human skin virome and its interactions with the host microbiome
GD Hannigan,1 J Meisel,1 A Tyldsley,1 Q Zheng,1 BP Hodkinson,1 AJ SanMiguel,1 S Minot,2 
FD Bushman2 and EA Grice1 1 Dermatology, University of Pennsylvania, Philadelphia, PA 
and 2 Microbiology, University of Pennsylvania, Philadelphia, PA
Viruses comprise a major component of the human microbiota, but are poorly understood in the 
skin. Viral communities have the potential to modulate states of cutaneous health and disease. 
Bacteriophages are known to influence the structure and function of microbial communities through 
predation and genetic exchange. Human viruses are associated with skin cancers and a multi-
tude of cutaneous manifestations. Here we evaluate human cutaneous virome-host interactions 
by comparing viral metagenomic sequence data to the total metagenome, sampled from sixteen 
subjects at eight body sites over a one-month time period. Skin virome community composition 
was most strongly associated with natural skin occlusion, contrasting partitioning of bacterial and 
fungal microbiota by skin microenvironment. Viral contigs were enriched for genes indicative of 
a temperate phage replication style, and also maintained genes encoding antibiotic resistance and 
virulence factors. CRISPR spacers identified in the bacterial DNA sequences provided a record of 
phage predation and suggest a mechanism to explain spatial partitioning of skin phage communities. 
Finally, we model the structure of bacterial and phage communities together to reveal a complex 
microbial environment with a Corynebacterium hub. These results reveal the previously underappre-
ciated diversity, encoded functions, and viral-microbial dynamic unique to the human skin virome.   
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Skin microbiome characterizations are biased by sequencing approach
J Meisel, GD Hannigan, A Tyldsley, AJ SanMiguel, BP Hodkinson, Q Zheng and EA Grice 
Dermatology, University of Pennsylvania, Philadelphia, PA
Alterations in composition and diversity of the skin microbiota have been linked to multiple der-
matological conditions. DNA sequence-based approches provide more comprehensive character-
ization of skin microbial communities compared to culture-based techniques. The most common 
approach relies upon amplification, sequencing, and analysis of specific regions of the 16S ribo-
somal RNA gene that are broadly conserved and taxonomically and phylogenetically informative. 
Unfortunately, no single region is able to distinguish among all bacteria and sequencing of the full 
gene is not practical using cost-effective next-generation sequencing technology. More recently, 
whole metagenomic shotgun (WMS) sequencing, without amplification of a marker gene, has been 
employed for both the taxonomic and functional annotation of skin microbiota. We hypothesize 
that each sequencing strategy has its own biases that affect the downstream characterization of 
the skin microbiota. In order to compare and identify ideal sequencing strategies to characterize 
the skin microbiome, we collected cutaneous swabs from a cohort of 20 healthy individuals at 12 
anatomical sites at 3 time points. We performed both 16S rRNA sequencing of hypervariable regions 
1-3 (V1-V3) and region 4 (V4). We compared these profiling results to WMS sequencing of the 
same swab samples. As an internal control, we applied the same strategies to a mock community 
of known bacterial strains in known quantities. Bioinformatics analysis identified both taxonomic 
and predicted functional differences depending on strategy. Notably, the V4 region of the 16S rRNA 
gene severely underestimates the abundance of Propionibacterium, a pervasive skin commensal 
and underestimates the diversity of samples taken from moist skin environments. These results 
highlight the importance of methodology in skin microbiome studies and provide experimental 
design guidelines for optimizing future findings.    
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Recirculating dermal IL-17-producing Vγ4+ γδT cells display memory-like responses
F Ramirez-Valle2 and J Cyster3, 1 1 Microbiology and Immunology, University of California 
San Francisco, San Francisco, CA, 2 Dermatology, University of California San Francisco, San 
Francisco, CA and 3 Howard Hughes Medical Institute, San Francisco, CA
We and others previously identified a population of migratory IL-17 committed γδT (γδT17) cells that 
are resident in dermis and lymph nodes. A critical role for γδT17 cells has been observed in several 
murine models of psoriasis. In addition to activation of γδT17 cells in the skin, topical treatment 
with imiquimod leads to their striking expansion in draining lymph nodes. Little is known about the 
behavior and fate of these cells after activation. We find that after proliferation in lymph nodes, Vγ4+ 
γδT17 cells migrate to perturbed skin where they exacerbate inflammation. Moreover, these cells 
migrate to other peripheral but not mucosal lymph nodes, and they colonize uninflamed skin where 
they persist for months. This altered composition resets the threshold for inflammation, sensitizing 
skin that had not previously been inflamed by imiquimod treatment. Compared to unsenstitized 
cells, quiescent, previously expanded Vγ4+ γδT17produce more IL-17 in the skin and proliferate 
more rapidly in responding lymph nodes upon rechallenge with imiquimod, exhibiting features 
of a memory response. In vitro, sensitized Vγ4+ γδT17 respond more robustly than naïve cells to 
suboptimal concentrations of IL1β, suggesting that the memory-like behavior of previously activated 
Vγ4+ γδT17 cells may be due at least in part to enhanced cytokine responsiveness.    
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TLSP induced phosphorylation of L-plastin in eosinophils and its implication in atopic 
dermatitis
J Noh,1 J Shin,1 S KIM1, 2, S Jin1, 2, H Lee,1 J Lee,1 H Chu,1 C Park3 and KH Lee1 1 Department 
of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University 
College of Medicine, Seoul, Korea (the Republic of), 2 Brain Korea 21 PLUS Project for 
Medical Science, Yonsei University College of Medicine, Seoul, Korea (the Republic of) and 
3 Dermatology, Brigham and Women’s Hospital, Boston, MA
TSLP induces the proinflammatory Th2 immune response and it plays an important role in allergic 
disease in skin and airway. In eosinophil, TSLP has been known to promote eosinophilic degranu-
lation and increase eosinophil survival. In this study, we attempted to find a novel protein which is 
regulated by TSLP in eosinophil to further understand the role of eosinophils in atopic dermatitis. In 
order to discover TSLP-regulated proteins in eosinophils, we performed two-dimensional Difference 
Gel Electrophoresis (2D-DIGE) analysis and identified 4 proteins by matrix-assisted laser desorption/
ionization-time of flight mass/mass spectrometry (MALDI-TOF MS/MS). Among the identified pro-
teins, we confirmed expression of Phospho-L-plastin on TSLP-treated/non-treated EOL-1 cells and 
blood eosinophils from healthy individuals (n=4) and atopic dermatitis patients (n=5) by Western 
blot. Chemotaxis of eosinophil was conducted in duplicate using 5um pore size chambers. In 
our results, TSLP (50ng/ml) increased phosphorylation of L-plastin in dose (10-100ng) and time 
(1-120min) dependent manner on EOL-1 cells. Although there was a slight increase, phosphorylation 
of L-plastin increased in eosinophils from atopic dermatitis compared to healthy individuals. Also, 
TSLP increased the migration of EOL-1 cells in dose (10-100ng) dependent manner. Compared to 
control, TSLP (50ng/ml) induced migration of EOL-1 cells (8.3 versus 25 % of total cells migrated, 
**p < 0.01). Since L-plastin is a leukocyte specific actin bundling protein and acts on cytoskeleton 
reorganization, integrin activation and signaling to NADPH oxidase, we suggest that phosphoryla-
tion of L-plastin by TSLP may affect the migration and the function of eosinophil in atopic dermatitis.   
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Spatial expression of RGD-binding integrins on keratinocytes control homeostatic and UV-in-
duced Langerhans cell migration by activating latent TGFβ
J Mohammed,1 A Bobr,2 B Astry,1 AG Bridges2 and D Kaplan1 1 Department of Dermatology, 
Center for Immunology, University of Minnesota, Minneapolis, MN and 2 Department of 
Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Dendritic cells resident in peripheral tissue migrate to regional lymph nodes where they initiate adap-
tive T cell responses. Langerhans cells (LC) are the sole dendritic cell population in the epidermis 
of mammalian skin. LC require autocrine Transforming Growth Factor beta1 (TGFβ) for epidermal 
residence and are thought to migrate in direct response to microbial and inflammatory cues while 
steady-state migration is thought to result from the disruption of homotypic e-cadherin bonds. In 
contrast, we find that homeostatic LC migration depends on the absence of Transforming Growth 
Factor beta1 (TGFβ) signaling in both mice and humans. Homeostatic LC migration was inhibited 
in mice with LC specific expression of a constitutively active form of the TGFβ receptor and patients 
treated with an inhibitor of TGFβ signaling showed reduced LC number. The RGD-binding integrins 
αvβ6 and αvβ8 that activate latent TGFβ are expressed in non-overlapping patterns by keratinocytes 
(KC) at inter follicular epidermis and isthmus region of the epidermis, respectively. Together they 
convert LC-derived inactive LAP-TGFβ into its active form that functions to prevent LC migration. 
Absence of αvβ6 and αvβ8 on KC results in complete loss of LC from the epidermis. In response to 
UV irradiation, αvβ6 and αvβ8 expression by KC and their ability to activate latent TGFβ are reduced 
resulting in activation-induced LC migration while induction of constitutively active TGFβ signaling 
in LC reduces their activation and migration. Contrary to the accepted model, these data demonstrate 
that signals from stromal cells can directly control homeostatic and UV-induced DC migration and 
reveal a novel mechanism of intercellular communication that is likely to occur in other cell types.   
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A requirement for pDC in the initiation of psoriasiform inflammation
A Griffith, M Hadiono, R Davis and D Popkin Dermatology, Case Western Reserve 
University, Cleveland, OH
Psoriasis is a common chronic immune-mediated disease of unknown origin. However, there is 
competing evidence that plasmacytoid dendritic cells (pDC) may be central to disease development. 
We developed a strategy to formally determine the role of pDC in non-xenograft psoriasiform mouse 
models to determine their causal role systemically, using the slc15a4feeble mutant mouse whose 
pDC do not respond to TLR agonists. Histology of the dorsal skin of slc15a4feeble mice treated for 5 
consecutive days with imiquimod, a topical TLR7 agonist, revealed decreased epidermal thickening 
as early as 24 hours post-treatment compared to wildtype (WT) mice. Additionally, immunohis-
tochemical staining of skin with markers for CD4, CD11c and Siglec H showed that slc15a4feeble 
mice have decreased immune cell infiltrates when compared to WT mice. Consistently, CRG-2 
and MIP-1b were present at significantly lower levels in feeble mice, demonstrating a dependence 
on pDC sensing for a complete immune response. However, we also found a regulatory role for 
pDC resulting in an increase in cytokines G-CSF, IL-1α, and LIX in feeble mice compared to WT. 
Interestingly and consistent with a potential regulatory role for pDC in skin inflammation, when 
we introduced a second model of inflammation by injecting IL-23 into the dermis of feeble vs. WT 
mice, feeble mice indeed developed epidermal thickening, suggesting pDC primarily play a role in 
the initiation of psoriasiform inflammation rather than in downstream indirect pathways. Our results 
suggest that pDC are necessary for the initiation of psoriasiform skin inflammation.    
559
Fisetin, a small molecule and a natural inhibitor of mTOR for treating psoriasis
J Chamcheu, M Chaves-Rodriquez, I Siddiqui, V Adhami, DN Syed, S Dodwad and 
H Mukhtar Dermatology, University of Wisconsin Madison, Madison, WI
Treatments for psoriasis, a chronic inflammatory skin disease remains elusive. Evidences suggest 
that the PI3K/Akt/ mTOR signaling may play an important role in the pathogenesis of psoriasis, 
where it is aberrantly upregulated, and is emerging as clinically relevant disease target. Identifying 
natural agents that possess the ability to abrogate these effects could be useful for the treatment 
of psoriasis. We recently reported that fisetin, a plant derived flavonoid, is a potent dual mTOR 
kinase inhibitor. Here, we investigated the effect of fisetin by employing both 2D normal human 
epidermal keratinocytes (NHEKs) cultures in the presence and absence of Interleukin 22 (IL-22), 
and imiquimod(IMQ)-induced psoriasis-like symptom in Balb/c mice. Fisetin (0-20 μM) -treated 
NHEK cultures pretreated with/without IL-22 showed a decrease in i) protein expression of PI3K 
and phosphorylated Akt, mTOR and downstream targets, ii) proliferation markers, and an increase 
in differentiation. Using a unique panel of different clinical grades of human psoriatic and imiqui-
mod(IMQ)-induced mouse psoriasis-like skin tissues, we observed Akt/mTOR pathway activation in 
skin lesions compared to matching controls. IMQ-exposed mice treated with fisetin (1mg/cm2/shaved 
skin/ear, topical) exhibited significantly decreased psoriasiform hyperplasia, reduced infiltration of 
mononuclear cells, decreased phosphorylation of Akt, mTOR and downstream targets and increased 
differentiation. Furthermore, fisetin-treated lesional skin tissues showed decreases in epidermal 
thicknesses, levels of inflammatory cytokines, proliferation (Ki-67/PCNA), Stat3 and splenic weight 
and increased differentiation when compared with control mice. Collectively, our data suggest a 
key role of PI3/Akt/mTOR in psoriasis and identify fisetin as a modulator of these targets. We suggest 
that fisetin, alone or as an adjuvant to current therapies, could be useful for treating psoriasis and 
potentially other hyperproliferative skin diseases, especially those that overexpress PI3K/AKT/mTOR.   
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LTA from commensal bacteria modulates keratinocyte SCF production to maintain mast 
cells in the skin 
Z Wang, X Sun and A Di Nardo Dermatology, UCSD, La Jolla, CA
Mast cells (MCs) play important roles in both innate and adaptive immunities and they are the only 
terminally differentiated hematopoietic cells that express the c-Kit receptor. Stem cell factor (SCF, 
also known as c-Kit ligand) is the crucial factor for the development, proliferation, and maturation 
of MCs. SCF can be produced locally in skin by epidermal keratinocytes, fibroblasts, and endothelial 
cells. Lipoteichoic acid (LTA), a constituent of skin commensal bacterial cell walls, induces SCF 
expression in keratinocytes. We confirmed that human skin presents with specific LTA staining 
that is absent in sterile, in vitro-cultured human keratinocytes (NHEKs). Adding 10μg/ml LTA for 24 
hours to in vitro-cultured NHEKs induced the appearance of LTA specific staining and increased SCF 
mRNA expression. Injection of 50μl of 10μg/ml LTA, intradermally, induced mouse keratinocyte SCF 
protein expression and increased MC numbers in vivo. In contrast, when we conditionally deleted 
SCF from keratinocytes using KRT14-cre SCFfl/fl mice, we found that MCs were depleted from skin, 
confirming that SCF produced by keratinocytes is necessary for MCs resident in the skin. Germ free 
(GF) mice are born in germ free conditions and are maintained in this environment throughout their 
life, thus, they should have no microbiome. In order to evaluate the presence of MCs in the skins 
of wild-type (WT), GF, and KitWsh-/- MC deficient mice, we measured chymase expression, which 
is tightly connected to the presence of mature skin MCs. Our experiments showed that KitWsh-/- MC 
deficient mice did not express chymase in the skin, while skin from GF mice expressed chymase 
at half the levels of WT mice. Therefore, mice with no microbiome and LTA, have either fewer 
overall or immature MCs residing in the skin. Therefore, we conclude that there are keratinocytes 
that maintain MCs in the skin and deliver the commensal signal to dermal MCs.    
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Opposing roles for Neurokinin-1 receptor in skin resident and circulating immune cells
Y Fritz, D Diaconu, M Camhi, T McCormick and NL Ward Dermatology, Case Western 
Reserve University, Cleveland, OH
Substance P (SP) is increased in psoriasis plaque and in KC-Tie2 mouse skin and nerve cell bodies 
(DRGs). Axotomy of nerves at their entry point into the skin resolved psoriasiform skin inflammation 
in KC-Tie2 mice and introducing SP back into denervated skin returned the T and dendritic cell 
(DC) phenotype back to innervated conditions. Chemical inhibition of SP resulted in similar disease 
improvement. To elucidate the criticality of SP interactions with it’s receptor, neurokinin-1 (NK1R) 
in promoting skin inflammation in the KC-Tie2 mouse model of psoriasis, we backcrossed KC-Tie2 
to NK1R-deficient (-/-) mice. Adult KC-Tie2 x NK1R-/- mouse skin had 37% fewer CD11c+ DCs (n=6 
ea; P=0.04 vs. KC-Tie2); but no difference in acanthosis or CD4+ T cells was observed. NK1R-/- mice 
treated with topical Aldara for 5 days had significant decreases in skin CD4+ T cells and CD11c+ 
DCs (n=10 ea; P<0.05). Together these data suggest that SP-NK1R contribute to T cell and DC 
skin infiltration in a model-dependent manner. In both models, changes in T cell- and DC-derived 
cytokine levels were not detected, perhaps reflective of whole skin lysates containing a mixed cell 
population and a “dilution” effect from other cells, such as KCs. To explore the importance of skin 
resident- vs. bone marrow (BM)-derived immune cells, BM from WT or NK1R-/- donor mice was 
transplanted into KC-Tie2 and WT (n=3-8) recipients; transplanted WT mice were then treated 
with Aldara. Surprisingly, KC-Tie2 mice receiving NK1R-/- BM developed further increases in skin 
inflammation (vs. KC-Tie2 with WT BM), evidenced by ~3-4-fold increase in skin IL-17A/F, IFNγ, 
IL-12p35 (P<0.05), suggesting that NK1R+ circulating immune cells may suppress inflammation 
rather than promote it. Similar increases in inflammation were observed in WT mice receiving NK1R-
/- BM followed by Aldara. Collectively our data suggest opposing roles for NK1R in skin-resident 
vs. circulating immune cells, such that NK1R+ resident skin cells are pro-inflammatory, whereas 
BM-derived NK-1R+ cells appear to be suppressive.    
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Robust induction of innate epidermal response genes by petrolatum sheds light on its function 
in preventing cutaneous infections
D Malajian,1 JM Corrêa da Rosa,1 A Shemer,2 JG Krueger1 and E Guttman-Yassky1, 3 
1 Laboratory for Investigative Dermatology, Rockefeller University, New York, NY, 2 
Department of Dermatology, Tel-Hashomer Hospital, Tel-Aviv, Israel and 3 Department of 
Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY
Petrolatum is a widely used moisturizer that provides clinical benefit to atopic dermatitis patients 
and is equivalent to topical antibiotics in the prevention of post-surgical skin infections. However, 
the mechanism by which petrolatum prevents infections and improves barrier function is presently 
unknown. We sought to assess molecular and cellular changes in petrolatum-occluded skin by 
evaluating biopsies of normal and petrolatum-occluded skin in 50 volunteers at 72 hours. We per-
formed gene-expression analysis by RT-PCR and gene arrays, and immunohistochemistry studies. 
Using criteria of fold change/FCH> 2 and false discovery rate/FDR<0.05 we detected 51 differentially 
expressed genes (DEGs) in petrolatum-occluded skin compared to control. Top genes up-regulated 
by petrolatum in both gene arrays and RT-PCR include key antimicrobial peptides (AMPs), such 
as elafin/PI3 (FCH=15.40), S100A8 (FCH=13.04), S100A9 (FCH=11.28), CCL20 (FCH=8.36), lipo-
calin 2/LCN2 (FCH=6.94) and beta defensin 4/hBD4 (FCH=4.96) (P<0.0001 or FDR<0.01 for all). 
Innate immune response genes (IL-8, IL-6, IL-1B) were also upregulated by petrolatum. Significant 
increases in these AMPs were mostly found in petrolatum-occluded skin, but not in occluded skin 
without petrolatum compared to control. IHC staining for hBD4 and S100A8/A9 showed increased 
granular expression and induced expression in the lower spinous epidermis. These data show that 
emollients have the potential to modulate epidermal function and provide a molecular basis for 
the role of petrolatum in the prevention of infections. These results may be used to develop skin 
structure-modifying treatments for normal and disease-states such as skin aging, AD, ichtyosis, skin 
infections and many others.    
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Clusters of dermal Bartonella henselae may be a functional biofilm
M Ericson,1 M Weber-Sanders,1 G Viera-Damiani,2 M Neves da Silva,2 V Pelegati,3 CL Cesar3 
and P Velho2 1 Dermatology, University of Minnesota, Minneapolis, MN, 2 Dermatology 
Division and Department of Medicin, UNICAMP, Campinas, Brazil and 3 National Institute 
of Science and Technology on Photonics Applied to Cell Biology (INFABIC), UNICAMP, 
Campinas, Brazil
Bartonella spp. can induce long-lasting bacteremia in mammals. Bartonella spp. are causative 
agents of cat-scratch disease, endocarditis, bacillary angiomatosis, bacillary peliosis, trench fever, 
neurocognitive dysfunction and regional pain syndrome. Chronic Bartonella spp. infection and 
subsequent manifestations of persistent infection may be the result of the bacteria growing in bio-
films. In humans, at least four Bartonella species have been associated with infectious endocarditis, 
a biofilm-associated infectious disease. Biofilms are sessile communities of interacting unicellular 
organisms that adhere to a surface and to each other and create unique, complex structures, cov-
ered with a protective layer of extracellular polymeric substances (EPS). Biofilms and their inherent 
resistance to antimicrobial agents are often key players in many persistent and chronic bacterial 
infections. We acquired skin biopsies from 5 patients with blood PCR-positive B. henselae. 60-100 
micron-thick sections were immunostained with antibodies to B.henselae and B.vinsonii. Stained 
sections were imaged using both single- and multi-photon imaging to capture epifluorescence 
emission and second harmonic generation signal of non-stained collagen I and II. The crystalline 
triple-helix of native fibrillar collagen (I, II, III and V) generates a strong second harmonic generation 
(SHG) signal. In patients with long-standing bartonellosis, clusters of immuno-reactive B. henselae 
and B. vinsonii were found intimately associated with collagen I and II in the dermis. Further, B. 
henselae, cultured 14 or 21 days, on collagen I and II-coated coverslips revealed a B. henselae bio-
film matrix. Identification and characterization of Bartonella spp. biofilms in vivo and in situ will lead 
to a better understanding of persistent bartonellosis and provide direction in treatment modalities.   
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A blockade of lysophosphatidic acid - lysophosphatidic acid receptor 1 cascade augments 
murine allergic skin inflammation
K Igawa, Y Itoh and H Yokozeki Dermatology, Tokyo Medical and Dental University, Tokyo, 
Japan
Lysophosphatidic acid (LPA) is a bioactive lipid that binds to a group of cell surface G protein-cou-
pled receptors (LPA receptors1-6 [LPAR1-6]) and has been implicated as an important mediator 
of angiogenesis, inflammation. Recently, the antagonists of LPAR1 (LPA1) reported to ameliorate 
murine collagen-induced arthritis, via inhibition of inflammatory cell migration and Th17 dif-
ferentiation. In this study, we examined the role of LPA-LPA1 cascade in murine allergic skin 
inflammation. Using 2,4,6-trinitrochlorobenzene (TNCB)-induced murine contact hypersensitivity 
model, we evaluated the effect of LPA1 in murine allergic skin inflammation. We compared the 
ear swelling reactions, represented skin inflammation, in LPA1-administrated mice and controlled 
mice. Histological analysis was also performed with the ear lobes of these mice. The cytokine or 
chemokine profiles in ear lobes of these mice were examined with ELISA kits. Ear swelling reactions 
were augmented in LPA1-administrated mice with dose dependent manner (around 30%-increase of 
controlled mice). Histologically, almost no differences were found in the characteristics of inflam-
matory cells in ear lobes between the controlled and the LPA1-administrated mice. The analysis 
of cytokines and chemokines in the ear lobes revealed that the production of IL-2, INF-gamma 
and IP-10, Th1 related cytokines and chemokines, were upregulated in LPA1-administrated mice. 
There were no differences between the controlled and LPA1-administrated mice, concerning the 
production of IL-17, Th17 related cytokines, and IL-4, IL-13 and TARC, Th2 related cytokines 
and chemokines in ear lobes. Collectively, these results indicate that the blockade of LPA-LPA1 
signaling contributes to the augmentation of murine skin allergic reaction by the upregulation of 
Th1 related immune reaction.    
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Dendritic cells display nanomolar sensitivity to zinc pyrithione-induced zinc ion dysregulation 
causing heat shock and metal stress response gene expression
SL Park and GT Wondrak Pharmacology and Toxicology, College of Pharmacy and Arizona 
Cancer Center, University of Arizona, Tucson, AZ
Dendritic cells (DCs) play a key role in the cutaneous innate and adaptive immune responses, and 
xenobiotic exposure is an important factor modulating DC function in human skin. Previously, we 
have demonstrated that zinc pyrithione (ZnPT), an FDA-approved over-the-counter topical antimi-
crobial, induces zinc dysregulation and heat shock response gene expression in cultured primary 
human skin keratinocytes and reconstructed epidermis. Here we demonstrate that DCs display an 
exquisite vulnerability to ZnPT, observable in the low nanomolar (> 25 nM) concentration range. 
In DCs (generated from CD34+ progenitor cells derived from umbilical cord blood) displaying the 
Langerhans cell phenotype (Langerin, Birbeck granules), expression array analysis revealed ZnPT-in-
duced upregulation of metal stress [MT2A (metallothionein 2A; 1600-fold)] and heat shock [CRYAB 
(crystallin, alpha B; 91-fold), HSPA6, HSPA1A, HSPB1, HSPH1, HSPA2, DNAJB4] response gene 
expression. Consistent with pronounced MT2A upregulation, FluoZin3-AM flow cytometric analysis 
revealed rapid induction of zinc ion overload. Occurrence of nuclear comets together with immu-
nodetection of poly(ADP-ribosylated)-protein and upregulation of GADD45A mRNA levels (growth 
arrest and DNA-damage-inducible, alpha; 17-fold) were indicative of ZnPT-induced impairment 
of genomic integrity. Upon prolonged exposure (24h; 50 nM), ZnPT-induction of cell death was 
detectable by annexinV-PI flow cytometry, an effect that was suppressed if ZnPT exposure occurred 
in the presence of the extracellular zinc ion chelator DTPA. At sublethal concentrations (< 25 nM) 
ZnPT exposure did not suppress LPS-induced release of immunoregulatory chemo- and cytokines 
(IL1β, IL6, IL12, RANTES, TNFα; ELISArrayTM, Qiagen). Taken together, our data demonstrate for the 
first time that DCs display a nanomolar sensitivity to the topical antimicrobial ZnPT, suggesting an 
immunomodulatory effect that may be of immunotoxicological or therapeutic relevance.    
566
Effect of IL-17 on an organotypic model of psoriasis
S Ayehunie, T Landry, Z Stevens, C Hedin, MA Bachelor, A Armento and M Klausner MatTek 
Corporation, Ashland, MA
Psoriasis is an inflammatory skin disease marked by hyperproliferation, abnormal keratinocyte 
(KC) differentiation, and leukocyte infiltration. Research into the pathogenesis of psoriasis has been 
hampered by the lack of animal models that accurately reflect the biology of psoriatic phenotype. 
Since IL-17 has been implicated in inflammatory skin diseases, we investigated the effects of IL-17 
on a reconstructed human psoriatic tissue model. Normal human keratinocytes (KC) and psoriatic 
fibroblasts from lesional and non-lesional sites were harvested from primary tissue and cultured 
using defined serum-free medium to form a highly differentiated 3-dimensional tissue model. We 
characterized genes and proteins that are induced by IL-17 in the reconstructed tissue model follow-
ing incubation with IL-17 for up to 96 hr. The results showed that: 1) psoriatic fibroblasts obtained 
from lesional and non-lesional sites can induce a psoriatic phenotype in vitro. RT-PCR analysis of 
the psoriatic tissue models showed overexpression (>2 fold) of HBD-2, psoriasin, elafin, and ENA-78 
when compared to normal reconstructed epidermal tissues. 2) IL-17 induces overexpression (1.5 
fold) of cytokines/chemokines that mediate chronic inflammation in psoriasis, such as CCL20 (a 
chemoattractant for both Th17 and dendritic cells), GCP-2 (ENA-78) and IL-8 (a chemoattractant for 
neutrophils) in a dose and time dependent manner, and 3) IL-17 increases IL-6, a known survival 
mediator of IL-17-producing Th17 cells. Overall, these results demonstrate that IL-17 exacerbates 
inflammation in the psoriatic tissue model by establishing a self-sustaining inflammatory feedback 
loop involving IL-17 and KC/fibroblast derived CCL20, IL-6, GCP-2, and IL-8. The availability of a 
well-characterized in vitro psoriatic tissue model will serve as a valuable tool to study the biology 
of psoriasis and to accelerate the development of therapeutics.    
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C-type lectin receptors upregulated in skin of Ptpn6/Shp-1-deficient mice with neutrophilic 
dermatosis-like disease
A Nesterovitch,1 Z Arbieva,3 D Toth,2 A Markovics,2 T Rauch,2 M Tharp1 and T Glant2 1 
Dermatology, Rush University Medical Center, Chicago, IL, 2 Orthopedic Surgery, Rush 
University Medical Center, Chicago, IL and 3 Core Genomics Facility, UIC, Chicago, IL
We found recently a new spontaneous mutation in the protein tyrosine phosphatase, nonreceptor 
type-6 (Ptpn6) gene in mice. All animals homozygous for meb2 mutation develop characteristic 
motheaten phenotype with patchy absence of hair and pigment in the skin and inflammation of the 
paws with erosions and ulcerations that resemble clinical and histopathological features of human 
neutrophilic dermatoses. We analyzed with Affymetrix microarrays and qPCR the differentially 
expressed genes in skin and bone marrow of meb2 mice and found that innate immunity C-type 
lectin receptors (Clec4e and Clec4d) were significantly upregulated in skin of meb2 mice (2(-ddCt) 
664 and 220, respectively) compare to the expression of toll-like receptor genes (Tlr1, Tlr2; 2(-ddCt) 
4.7 and 3.8) and integrins (Itgam (CD11b) 2(-ddCt) 6.1; Itgax (CD11c) 1.6; Itgb2 (CD18) 15.4). C-type 
lectin receptors recognize variety of ligands such as damaged cells, fungus (Candida and Malassezia 
species), mycobacteria and play an important role in innate immunity. The activating signals from 
Clec4e and Clec4d receptors are carried though immunoreceptor tyrosine-based activation motif 
(ITAM) with recruitment and activation of the spleen tyrosine kinase (Syk). The interference of the 
signaling from C-type lectin receptors via Syk might explain that mice with double full length dele-
tions of Ptpn6 and Syk genes restricted to neutrophils (Ptpn6(fl/fl)Syk(fl/fl)S100a8-cre) are completely 
free of skin inflammation.    
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SIG1191: A novel cosmetic functional ingredient with anti-inflammatory properties and 
skin hydrating potential
JR Fernandez,1 K Rouzard,1 M Voronkov,1 KL Huber,1 C Webb,1 JB Stock,2 M Stock,1 
JS Gordon1 and E Perez1 1 Signum Dermalogix, Princeton, NJ and 2 Molecular Biology, 
Princeton University, Princeton, NJ
Isoprenylcysteine compounds that modulate the intracellular signal transduction activity of G-pro-
teins have been shown to regulate the in vitro responses of inflammatory cells. Topical in vivo 
anti-inflammatory activity of the archetype of this class: N-acetyl-S-farnesylcysteine (AFC), was 
subsequently established leading to its use as a cosmetic ingredient in skin care products. We report 
here, a second generation IPC derivative of AFC, SIG1191 shows anti-inflammatory activity when 
applied topically in the in vivo TPA mouse ear assay, reducing edema, neutrophil infiltration and 
erythema. SIG1191 also demonstrates anti-inflammatory properties in vitro reducing UVA, UVB and 
TPA induced pro-inflammatory cytokine production in primary human keratinocytes and fibroblasts. 
Furthermore, SIG1191 inhibits inflammatory mediator COX-2 gene expression in cultured skin 
equivalents. In addition to its anti-inflammatory properties, we present here that SIG1191 poten-
tially targets skin hydration and aging by modulating Aquaporin-3 (AQP3) expression. Aquaporin-3 
(AQP3) and Aquaporin-9 (AQP9) regulate osmotic balance as integral pore forming cell membrane 
proteins facilitating water, urea and glycerol transport across cell membranes. They are both con-
stitutively expressed by keratinocytes at the basal layer of the epidermis and are thus involved in 
regulating skin hydration. AQP3 expression levels have also been shown to decrease in response to 
both UVB exposure and skin aging. Here, we report SIG1191 dose-dependently stimulates AQP3 
gene expression in both monolayer keratinocytes and 3D skin equivalent cultures. Results show 
that only AQP3 is dose-dependently increased by SIG1191, whereas AQP9 is not affected. Increase 
of AQP3 expression was independent of PPARγ activation. Altogether, these studies demonstrate 
SIG1191 is a novel cosmetic ingredient that can potentially provide skin hydration by increasing 
Aquaporin-3 and possesses anti-inflammatory properties to help protect the skin.    
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xMAP® technology and tape stripping: High-throughput profiling of stratum corneum IL-1RA 
and IL-1α
N Parisi,1 PJ Matts,2 R Lever,1 J Hadgraft1 and ME Lane1 1 UCL School of Pharmacy, London, 
United Kingdom and 2 Procter & Gamble Technical Centre, Egham, United Kingdom
The ratio of stratum corneum (SC) interleukin 1 receptor antagonist (IL-1RA) and interleukin 1α 
(IL-1α) is a useful parameter which provides information on skin microinflammatory status. In the 
present study Luminex® xMAP® technology was combined with tape stripping, an established SC 
sampling technique, to investigate the in vivo distribution of IL-1RA and IL-1α across SC as a function 
of anatomic site. An xMAP® assay for simultaneous detection of IL-1RA and IL-1α was developed 
and validated. The assay was used to analyse tape strips of the volar forearm, outer lower leg and 
cheek of twelve healthy volunteers, whereas the protein content on the tapes was measured using 
an infrared densitometer. Since protein content on the tape strips changed with depth and body 
site (one-way ANOVA, p < 0.01), IL-1RA and IL-1α content were normalized to amount of protein. 
The forearm and the lower leg showed statistically higher amounts of IL-1α compared with IL-1RA, 
while the opposite was observed in the cheek (Mann-Whitney U Test, p < 0.001). When comparing 
different sites, the forearm and the lower leg did not show significant differences in their IL-1RA and 
IL-1α content. However, a statistically higher amount of IL-1RA and a lower amount of IL-1α were 
found in the cheek when compared with forearm and lower leg (Kruskal-Wallis Test, p < 0.01). With 
respect to their distribution across SC, the amounts of both IL-1RA and IL-1α and their ratio did not 
change with increasing depth for 16 consecutive tape strips from forearm and lower leg and 8 from 
the cheek. Finally, although no differences were seen between the IL-1RA:IL1α ratio of the forearm 
and the lower leg, the cheek showed a significantly higher ratio than other sites (Kruskal- Wallis 
Test, p < 0.01). This is the first report of the application of Luminex® xMAP® technology with tape 
stripping to profile these biomarkers in different anatomic sites. We are currently examining the 
potential of these assays to determine effects of personal care formulations on skin health.    
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The cytosolic nucleic acid-sensing pathways play critical roles in host restriction of modified 
vaccinia virus Ankara replication
W Wang,1 C Serna-Tamayo,1 Z Niu,1 P Dai2, 1, S Shuman2 and L Deng1 1 Dermatology 
Service/Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 
and 2 Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY
We investigate the role of the cytosolic nucleic acid-sensing pathways in skin antiviral immunity 
using vaccinia virus (a DNA virus) as a model system. cGAS (cyclic GMP-AMP synthase) is a newly 
discovered cytosolic DNA sensor. Upon DNA binding, cGAS is activated and produces a second 
messenger c[G(2’,5’)pA(3’,5’)p] (cGAMP), which leads to the activation of an adaptor molecule 
STING (stimulator of IFN genes) and its downstream signaling pathway. MDA5 (melanoma differ-
entiation-associated protein 5) is a cytosolic dsRNA sensor. Upon dsRNA binding, it interacts with 
its adaptor molecule MAVS (mitochondrial antiviral signaling protein), which leads to activation of 
transcription factor IRF3 (IFN regulatory factor 3). We recently reported that modified vaccina virus 
Ankara (MVA), a highly attenuated vaccinia virus (a DNA virus), triggers type I IFN production in 
conventional dendritic cells (cDCs) via a cGAS/STING- and IRF3/IRF7-dependent pathway. Here 
we report that the STING-mediated cytosolic DNA-sensing pathway and MDA5-mediated cytoslic 
dsRNA-sensing pathway play critical roles in restricting MVA replication in immortalized murine 
embryo fibroblasts (MEFs). Compared with WT controls, MVA replication was increased by 150-
fold in STING-deficient MEFs, by 50-fold in MDA5-deficient MEFs, and by 1333-fold in STING 
and MDA5 double-deficient MEFs. Infection of MEFs by MVA induces phosphorylation of IRF3, 
which was abolished in STING-deficient cells. These results indicate that both the cytosolic DNA 
and dsRNA-sensing pathways play critical and non-redundant roles in restricting MVA replication 
in MEFs. We found that MVA infection is non-permissive in human adult or neonatal fibroblasts. 
Studies are underway to test whether knock-down of cGAS, STING, or MDA5 in human fibroblasts 
would permit MVA replication in these cells. The results of our study provide insights into skin 
antiviral immunity.    
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Lewisite-induced cutaneous injuries in murine skin
M Athar, C Li, RK Srivastava, Z Weng and F Afaq Dermatology, University of Alabama at 
Birmingham, Birmingham, AL
Lewisite (dichloro (2-chlorovinyl) arsine) is a potent arsenic-based blistering agent which possesses 
significant toxicity both topically and systemically. It was developed during World War I as a chem-
ical weapon and has been stockpiled by several countries. Lewisite is highly irritating to the skin, 
eyes, and airways. Cutaneous exposure to lewisite was known to induce painful inflammation and 
blistering. However, the molecular mechanism of pathogenesis of this response remains undefined. 
In addition, there is no effective antidote so far described. Here, we show that topical application 
of lewisite induced potent acute inflammation and microvesication associated with the generation 
of reactive oxygen species (ROS) and massive apoptosis in the skin of Ptch+/-/SKH-1 hairless mice. 
This murine model was found to be highly sensitive to arsenicals-induced cutaneous inflammation 
and blistering as compared to other murine models. Employing PCR array, we observed that out 
of 84 inflammation-related genes, 25 upregulated, 37 downregulated and remaining 22 showed 
no significant changes. We also found that lewisite-induced skin lesions in these animals were 
regulated via activation of ROS-dependent unfolded protein response (UPR) signaling pathway. Out 
of three branches of UPR signaling, the ATF4-CHOP pathway was highly induced whereas other 
two regulated by IRE1 and ATF6 were not significantly altered. A dose-dependent up-regulation 
of inflammatory response, UPR signaling, and apoptosis was also observed in lewisite-treated 
human skin keratinocytes. Treatment of lewisite-exposed mice with antioxidant N-acetylcysteine 
(NAC) attenuated lewisite-induced skin injuries. The inhibition of lewisite-induced pathobiological 
responses was associated with the reduced ROS production, diminished expression of ATF4 and 
CHOP as well as apoptosis. This study unravels a novel molecular mechanism involved in the 
pathogenesis of lewisite-induced cutaneous lesions and identifies possible therapeutic targets for 
lewisite-mediated cutaneous inflammation and vesication.    
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IL-27 participates in cutaneous host immune suppression in leprosy
K Kelly-Scumpia, RM Teles and R Modlin Medicine/Dermatology, UCLA, Los Angeles, CA
The production of interleukin (IL)-10 during infection by intracellular pathogens contributes to 
suppression of cutaneous host defense responses. One pathway by which IL-10 is induced during 
microbial infection involves the ability of such pathogens to trigger type I interferons (IFNs), yet the 
mechanism by which type I IFN induces IL-10 remains unclear. Our studies of gene expression pro-
files in leprosy lesions suggested a link between IL-27 and the IFN-β induced IL-10 pathway. Here, 
we demonstrate that the IL-27p28 subunit is upregulated following treatment of monocytes with IFNβ 
or Mycobacterium leprae, the intracellular bacterium that causes leprosy. The ability of IFNβ and M. 
leprae to induce IL-10 was diminished by IL-27 knockdown. Additionally, treatment of monocytes 
with recombinant IL-27 was sufficient to induce the production of IL-10. Functionally, IL-27 inhib-
ited the ability of IFN-γ to trigger antimicrobial activity against M. leprae in infected monocytes. At 
the site of disease, IL-27 was more strongly expressed in skin lesions of patients with progressive 
lepromatous leprosy, correlating and colocalizing with IFN-β and IL-10 in macrophages. Together, 
these data provide evidence that in human cutaneous immune responses to microbial infection, 
IL-27 triggers IL-10 production, contributing to the suppression of host antimicrobial responses.   
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Negative regulation of noncanonical NF-kB signaling
B Razani 1 Dept. of Microbiology, Immunology, and Molecular Genetics, UCLA, Los 
Angelesc, CA and 2 Dept. of Dermatology, UCSF, San Francisco, CA
Hyperactivation of noncanonical NF-kB signaling has been shown to play a role in autoimmune 
diseases, such as Systemic Lupus Erythematosus, as well as proliferative diseases, including hema-
topoietic cancers and most recently melanoma. While the activation of this pathway downstream 
of specific receptors has been studied in detail, how the noncanonical NF-kB pathway is negatively 
regulated following receptor activation is not understood. Here we show that NIK, the central 
regulatory kinase of the pathway, is phosphorylated and degraded by its downstream target, the 
kinase IKKa. This phosphorylation occurs on specific residues of the NIK c-terminus. When this 
negative regulatory phosphorylation event is abrogated, noncanonical NF-kB signaling is hyperac-
tive. Together our work demonstrates the existence of a negative feedback phosphoryation-loop in 
which receptor activation and signaling through the noncanonical NF-kB pathway sets in motion 
degradative phosphorylation of its central kinase, NIK.    
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Macrophages infected with Mycobacterium leprae fail to activate appropriate antimicrobial 
pathways
PO Scumpia,2 G Botten,1 K Kelly-Scumpia,2 R Modlin2, 1 and S Smale1 1 Microbiology, 
Immunology, and Molecular Genetics, UCLA, Los Angeles, CA and 2 Dermatology, UCLA, 
Los Angeles, CA
Leprosy is a disease caused by the cutaneous pathogen Mycobacterium leprae (mLEP). Much of what 
has been learned about cutaneous host defense to mLEP was learned through studying established 
disease, by studying the skin lesions of patients with either the progressive, lepromatous form of 
the disease or the self-limited, tuberculoid form of the disease. Pathogen associated molecular 
patterns on mLEP, such as the 19 kDa lipoprotein have been identified that activate protective 
host defense responses in tuberculoid leprosy (T-lep) through Toll-like receptor (TLR)2. The initial 
responses of immune cells upon exposure to mLEP are not well characterized Herein, our goals were 
to determine the early transcriptional responses in macrophages upon exposure to mLEP.Human 
monocyte derived macrophages (MDMs) were cultured with either M-CSF and stimulated with 
TLR2 agonist, live, or irradiated mLEP (multiplicity of infection of 5) for various time points. Then, 
mRNA was extracted and a high-throughput RNASequencing (RNASeq)-based systems approach 
was employed high to investigate transcriptome responses. Treatment of human macrophages in 
vitro with live mLEP induced a robust time-dependent global activation transcriptional signal. 
However, this differed dramatically from the signature induced by TLR2 agonist. While the TLR2 
signature was dominated by a strong NF-kB-dependent signature, live mLEP was unable to induce 
NF-kB dependent genes strongly. Importantly, genes encoding IL-12, cathelicidin, and Cyp27b1, 
important for host defense to mLEP were not induced by live mLEP. Instead, there was a strong 
type I interferon dependent signature that was greatest in macrophages treated with live mLEP. 
The response to irradiated mLEP was similar to that of live mLEP, except with a weaker interferon 
signature. Our findings argue that the initial response to mLEP is dominated by type I IFN production 
and a failure to induce protective immunity, similar to the signature observed in the skin of patients 
with lepromatous leprosy.    
